<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Evid Based Complement Alternat Med</journal-id><journal-id journal-id-type="iso-abbrev">Evid Based Complement Alternat Med</journal-id><journal-id journal-id-type="publisher-id">ECAM</journal-id><journal-title-group><journal-title>Evidence-based Complementary and Alternative Medicine : eCAM</journal-title></journal-title-group><issn pub-type="ppub">1741-427X</issn><issn pub-type="epub">1741-4288</issn><publisher><publisher-name>Hindawi</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7826218</article-id><article-id pub-id-type="doi">10.1155/2021/3796265</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>The Effect of <italic>Momordica charantia</italic> in the Treatment of Diabetes Mellitus: A Review</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Zhuo</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Gong</surname><given-names>Jing</given-names></name><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Huang</surname><given-names>Wenya</given-names></name><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Lu</surname><given-names>Fuer</given-names></name><xref ref-type="aff" rid="I3">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-4771-0846</contrib-id><name><surname>Dong</surname><given-names>Hui</given-names></name><email>tjhdonghui@163.com</email><xref ref-type="aff" rid="I3">
<sup>3</sup>
</xref></contrib></contrib-group><aff id="I1">
<sup>1</sup>Grade 2016 of Integrated Traditional Chinese and Western Clinical Medicine, Huazhong University of Science and Technology, Wuhan, China</aff><aff id="I2">
<sup>2</sup>Department of Integrated Traditional Chinese and Western Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China</aff><aff id="I3">
<sup>3</sup>Institute of Integrated Traditional Chinese and Western Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China</aff><author-notes><fn fn-type="other"><p>Academic Editor: Riaz Ullah</p></fn></author-notes><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>16</day><month>1</month><year>2021</year></pub-date><pub-date pub-type="pmc-release"><day>16</day><month>1</month><year>2021</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. --><volume>2021</volume><elocation-id>3796265</elocation-id><history><date date-type="received"><day>21</day><month>7</month><year>2020</year></date><date date-type="rev-recd"><day>2</day><month>12</month><year>2020</year></date><date date-type="accepted"><day>18</day><month>12</month><year>2020</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2021 Zhuo Liu et al.</copyright-statement><copyright-year>2021</copyright-year><license xlink:href="https://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>In recent years, many studies of <italic>Momordica charantia</italic> (MC) in the treatment of diabetes mellitus (DM) and its complications have been reported. This article reviewed the effect and mechanism of MC against diabetes, including the results from in vitro and in vivo experiments and clinical trials. The common side effects of MC were also summarized. We hope that it might open up new ideas for further mechanism exploration and clinical application as well as provide a scientific theoretical basis for the development of drugs or foods derived from MC.</p></abstract><funding-group><award-group><funding-source>National Key R&#x00026;D Program of China</funding-source><award-id>2018YFC1704202</award-id></award-group><award-group><funding-source>National Natural Science Foundation of China</funding-source><award-id>81874382</award-id><award-id>81904158</award-id><award-id>81904011</award-id></award-group></funding-group></article-meta></front><body><sec id="sec1"><title>1. Introduction</title><p>Diabetes is a metabolic disease with typical hyperglycemia manifestations, such as polydipsia, polyphagia, polyuria, impaired vision and body weight [<xref rid="B1" ref-type="bibr">1</xref>]. With the increase of high-caloric dietary intake and sedentary lifestyle, the number of diabetic patients has increased dramatically. In light of statistics from the World Health Organization in 2016, 422 million people had diabetes in 2014, and the incidence has risen substantially since 1980 [<xref rid="B2" ref-type="bibr">2</xref>]. It is no longer particularly and commonly seen in affluent areas, as the prevalence in relatively backward areas is rising even faster [<xref rid="B2" ref-type="bibr">2</xref>]. Diabetes is generally divided into four categories: type 1 diabetes (T1DM) (autoimmune <italic>&#x003b2;</italic>-cell destruction usually accompanied by absolute insulin deficiency), type 2 diabetes (T2DM) (a gradual decrease in <italic>&#x003b2;</italic>-cell insulin secretion), gestational diabetes, and specific types of diabetes [<xref rid="B3" ref-type="bibr">3</xref>]. It is a chronic disease which can damage the heart, blood vessels [<xref rid="B4" ref-type="bibr">4</xref>], ocular surface [<xref rid="B5" ref-type="bibr">5</xref>], nerves [<xref rid="B6" ref-type="bibr">6</xref>], and musculoskeletal system [<xref rid="B7" ref-type="bibr">7</xref>] gradually and has become the leading cause of kidney failure [<xref rid="B8" ref-type="bibr">8</xref>] and blindness [<xref rid="B9" ref-type="bibr">9</xref>]. Insulin injection and oral hypoglycemic agents are always used to reduce blood glucose levels. Besides, lifestyle management is also recommended fundamentally. However, because of the poor medication compliance [<xref rid="B10" ref-type="bibr">10</xref>] and limited access of large populations to conventional antidiabetic drugs, together with the inevitable side effects and resistance of western medicine [<xref rid="B11" ref-type="bibr">11</xref>], patients have always been trying to find some effective natural plants, for instance, Indian Ayurvedic medicine, African traditional medicine, Japanese Kampo medicine, and Chinese herbs [<xref rid="B12" ref-type="bibr">12</xref>].</p></sec><sec id="sec2"><title>2. Overview of <italic>Momordica charantia</italic> L</title><p>
<italic>Momordica charantia</italic> L., also known as bitter gourd, bitter melon, or karela, is an annual climbing plant of the family Cucurbitaceae. It is native to East India and is widely grown and eaten in tropical, subtropical, and temperate regions at present. The vegetable is light green with a long cone shape; it tastes bitter but is popular for its various benefits [<xref rid="B13" ref-type="bibr">13</xref>]. There are many nutrients in this plant [<xref rid="B14" ref-type="bibr">14</xref>, <xref rid="B15" ref-type="bibr">15</xref>]. With the deepening of research on MC, numerous phytochemicals have been discovered, including saponins, polysaccharides, triterpenes, proteins, vitamins, minerals, flavonoids, ascorbic acid, and steroids [<xref rid="B16" ref-type="bibr">16</xref>]. Besides, multiple biological characteristics have also been confirmed, such as antioxidant, hypoglycemic, antitumor, antibacterial [<xref rid="B17" ref-type="bibr">17</xref>], skin care [<xref rid="B18" ref-type="bibr">18</xref>], anthelmintic, neuroprotective, anti-inflammatory, antiviral, immunomodulatory, wound healing promoting, antimutagenic, antiulcer, liver protection, and antiobesity activities [<xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B19" ref-type="bibr">19</xref>&#x02013;<xref rid="B21" ref-type="bibr">21</xref>]. It commonly serves as four dosage forms: fruit juice, freeze-dried powder, entire fruit, or capsule, and the preparations are mainly crude extracts (usually extracted with water, ethanol, or methanol) and effective monomer components extracted from its fruit, seeds, or leaves [<xref rid="B22" ref-type="bibr">22</xref>]. As a multifunctional vegetable, MC plays a vital role in traditional medicine in China, India [<xref rid="B13" ref-type="bibr">13</xref>], Mauritius [<xref rid="B23" ref-type="bibr">23</xref>], Turkey [<xref rid="B24" ref-type="bibr">24</xref>], and other Asian and African regions [<xref rid="B25" ref-type="bibr">25</xref>]. Nowadays, the research on various potentials of MC is in full swing, and the antidiabetic effect is of particular concerns. In this review, the reports on the treatment of diabetes by MC were summarized.</p></sec><sec id="sec3"><title>3. Antidiabetic Efficacy and Mechanism of <italic>Momordica charantia</italic></title><sec id="sec3.1"><title>3.1. Enhancing Glucose Uptake, Consumption, and Utilization</title><sec id="sec3.1.1"><title>3.1.1. Cell Experiments</title><p>Cytological research concentrates on studying the influence of MC on insulin signaling pathways of insulin-targeted cells such as hepatocytes, skeletal muscle cells, and adipocytes. The mechanisms of MC concentrate on improving insulin resistance through enhancing glucose uptake, consumption, and utilization.</p><p>A novel insulin receptor-binding protein from <italic>Momordica charantia</italic> (mcIRBP) was separated from MC. A further study identified mcIRBP-9 and confirmed the gastric resistance and hypoglycemic activity of the peptides [<xref rid="B26" ref-type="bibr">26</xref>]. The protein physically interacts with the insulin receptor (IR) through the binding sites different from that of insulin, and it shows a synergistic effect with insulin, enhancing the kinase activity of IR by 5.87&#x02009;&#x000b1;&#x02009;0.45 times and increasing the amount of phospho-IR protein by 1.31&#x02009;&#x000b1;&#x02009;0.03 times. All in all, mcIRBP motivated the glucose consumption of cells by 1.36&#x02009;&#x000b1;&#x02009;0.12 times via affecting IR/phosphoinositide-3-kinase (PI3K)/protein kinase B (Akt) pathways and consequently promoting translocation of glucose transporter 4 (GLUT4) [<xref rid="B27" ref-type="bibr">27</xref>].</p><p>The research on cucurbitane-type glycosides isolated from MC shows that the compounds can increase the uptake of glucose by the C2C12 myoblasts [<xref rid="B17" ref-type="bibr">17</xref>], and they exert antidiabetic effect by behaving as a stronger adenosine 5&#x02032;-monophosphate-activated protein kinase (AMPK) activator than troglitazone [<xref rid="B28" ref-type="bibr">28</xref>]. However, one study demonstrates that the cucurbitane-type triterpenoids can stimulate glucose utilization in C2C12 myotubes through insulin receptor substrate-1 (IRS-1) signaling pathway in skeletal muscle instead of adipose tissue and liver tissue [<xref rid="B29" ref-type="bibr">29</xref>]. Besides, MC juice can stimulate glucose elimination in L6 myotubes [<xref rid="B30" ref-type="bibr">30</xref>], and the protein extract of MC has similar effect on C2C12 myocytes and 3T3-L1 adipocytes as well [<xref rid="B31" ref-type="bibr">31</xref>]. Interestingly, it was observed that a standardized MC fruit ethanolic extract improved glucose uptake of hemidiaphragm in vitro [<xref rid="B32" ref-type="bibr">32</xref>], and a further study indicated that MC juice could do it in the presence and absence of insulin [<xref rid="B33" ref-type="bibr">33</xref>]. Moreover, it has been reported that bitter gourd methanol extract can promote glucose uptake of insulin-resistant FL83B cells [<xref rid="B28" ref-type="bibr">28</xref>]. Therefore, we speculate that MC may have a hypoglycemic effect in a non-insulin-dependent manner and show an insulin signaling pathway-enhancing effect.</p><p>Additionally, it has been recorded in the literature that three insulin-like active compounds from bitter gourd can block the active site of glycogen synthase kinase 3 (GSK-3) by combining with it, thus reducing the inactivation of glycogen synthase (GS) and further restoring glycogen content [<xref rid="B34" ref-type="bibr">34</xref>] (<xref ref-type="fig" rid="fig1">Figure 1</xref>).</p></sec><sec id="sec3.1.2"><title>3.1.2. Animal Experiment</title><p>Animal experiments mostly focus on the therapeutic effect of MC on T2DM through ameliorating insulin signal transduction disorder, while there are few documents confirming the impact of MC on T1DM. In the treatment of diabetic rats induced by high-fat diet (HFD) and streptozocin (STZ), the ethanol extract functions by downregulating the expression of suppressors-of-cytokine-signaling 3 (SOCS-3) and c-Jun N-terminal kinase (JNK), improving IRS-1/PI3K signal transduction, and upregulating the expression of Akt-2 and GLUT-4 in skeletal muscle and liver tissues, as well as increasing liver glycogen content [<xref rid="B35" ref-type="bibr">35</xref>] (<xref ref-type="fig" rid="fig1">Figure 1</xref>). In diabetic rats fed with HFD, MC powder motivates insulin signaling through elevating phospho-IRS-1 (Tyr612) and phospho-Akt (Ser473) in muscle and liver, along with lowering phospho-JNK (Thr183/Tyr185) in muscle, liver, and epididymal adipose [<xref rid="B36" ref-type="bibr">36</xref>]. Moreover, it is found that MC juice can increase the glucose uptake of skeletal muscle via PI3K pathway [<xref rid="B30" ref-type="bibr">30</xref>]. Aqueous extract is able to improve the protein expression of IRS-1 in liver tissue and GLUT4 in skeletal muscle so as to enhance glucose utilization in HFD-induced T2DM KK/HI mice, but not in STZ-induced T1DM ICR mice [<xref rid="B37" ref-type="bibr">37</xref>]. In 2006, cucurbitane triterpenoids isolated from MC were first proved to have hypoglycemic activity in male ddY diabetic mice [<xref rid="B38" ref-type="bibr">38</xref>]. Further studies on STZ- and alloxan- (ALX-) induced DM mice models have revealed that such compounds increase the activation of IRS-1/PI3K/Akt pathway, leading to translocation of GLUT4 and suppression of GSK-3<italic>&#x003b2;</italic>, thereby stimulating glucose uptake by skeletal muscle [<xref rid="B29" ref-type="bibr">29</xref>] and other tissues, increasing liver glycogen content at the same time [<xref rid="B39" ref-type="bibr">39</xref>]. As we have mentioned above, MC contains a novel insulin receptor-binding protein, mcIRBP, which can combine with IR and activate downstream signal transduction pathways [<xref rid="B27" ref-type="bibr">27</xref>]. An experiment on T1DM mice indicated that oral administration of mcIRBP-9 for 30 days resulted in the clearance of blood glucose and a distinct reduction in hemoglobin A1c (HbA1c) levels [<xref rid="B26" ref-type="bibr">26</xref>].</p><p>Other metabolic signaling pathways involved in the hypoglycemic effect of MC were also investigated. Research on T2DM KK-Ay mouse model suggests that water extract of MC affects glucose utilization by activating AMPK in muscle tissue [<xref rid="B40" ref-type="bibr">40</xref>]. Studies on obese rats have shown that MC enhances the activity of AMPK by stimulating the production and function of thyroid hormones and adiponectin, bringing about the increase and translocation of GLUT4 [<xref rid="B41" ref-type="bibr">41</xref>]; bitter melon juice exhibits the function of alleviating insulin resistance, and the mechanism may involve the upregulation of leptin and adiponectin [<xref rid="B42" ref-type="bibr">42</xref>] (<xref ref-type="fig" rid="fig1">Figure 1</xref>). In ALX-induced DM mice model, saponins from MC have a significant effect on activating AMPK, which promotes glycogen synthesis [<xref rid="B43" ref-type="bibr">43</xref>] via glycogen synthase [<xref rid="B44" ref-type="bibr">44</xref>]; cucurbitane triterpenoids can improve cellular uptake of glucose via upregulating the transcription levels of AMPK-<italic>&#x003b1;</italic>1 and GLUT4 [<xref rid="B39" ref-type="bibr">39</xref>]. In addition, in vivo and in vitro research has found that MC extract can influence peroxisome proliferator-activated receptor (PPAR) PPAR<italic>&#x003b1;</italic>/PPAR<italic>&#x003b3;</italic> and further regulate acyl-CoA oxidase (ACO) [<xref rid="B45" ref-type="bibr">45</xref>, <xref rid="B46" ref-type="bibr">46</xref>], leptin, and resistin, increasing glucose utilization of adipocytes in HFD mice consequently [<xref rid="B47" ref-type="bibr">47</xref>] (<xref ref-type="fig" rid="fig1">Figure 1</xref>).</p></sec></sec><sec id="sec3.2"><title>3.2. Delaying Glucose Absorption</title><sec id="sec3.2.1"><title>3.2.1. Cell Experiment</title><p>An experiment was performed to assess the inhibitory activity of protein extracts from two kinds of bitter melon on <italic>&#x003b1;</italic>-amylase and <italic>&#x003b1;</italic>-glucosidase, and it showed that their inhibition rate (66% to 69%) and IC50 (0.26 to 0.29&#x02009;mg) were comparable to acarbose [<xref rid="B48" ref-type="bibr">48</xref>]. It has been proved that the inhibitory activity of MC ethanol extract on pancreatic lipase and <italic>&#x003b1;</italic>-glucosidase is performed in a dose-dependent manner [<xref rid="B49" ref-type="bibr">49</xref>]. Moreover, the suppression of the ethyl acetate fraction of MC extract on pancreatic lipase is positively correlated with its phenol content [<xref rid="B50" ref-type="bibr">50</xref>]. Momordicin, a compound identified from MC, acted against <italic>&#x003b1;</italic>-amylase with IC50 of 15.86&#x02009;<italic>&#x003bc;</italic>g/ml [<xref rid="B51" ref-type="bibr">51</xref>]. An acidic and branched heteropolysaccharide obtained from MC was found to have 89.1% <italic>&#x003b1;</italic>-amylase inhibitory property [<xref rid="B52" ref-type="bibr">52</xref>]. The inhibitory activity of cucurbitane-type compounds in <italic>&#x003b1;</italic>-glucosidase and <italic>&#x003b1;</italic>-amylase has also been observed [<xref rid="B53" ref-type="bibr">53</xref>, <xref rid="B54" ref-type="bibr">54</xref>]. The inhibitory properties of compounds 1&#x02013;7 isolated from MC on <italic>&#x003b1;</italic>-glucosidase and <italic>&#x003b1;</italic>-amylase are between 35% and 70%; besides, gentisic acid 5-O-<italic>&#x003b2;</italic>-d-xyloside and momordicoside G showed the strongest effect on <italic>&#x003b1;</italic>-glucosidase (56.4%) and <italic>&#x003b1;</italic>-amylase (70.5%), respectively [<xref rid="B55" ref-type="bibr">55</xref>]. Total anthocyanins from bitter melon [<xref rid="B56" ref-type="bibr">56</xref>], oil, and polypeptide-k extracted from MC seeds [<xref rid="B57" ref-type="bibr">57</xref>] can also contribute to the inhibitory effect of MC on <italic>&#x003b1;</italic>-glucosidase and <italic>&#x003b1;</italic>-amylase. Besides, it is suggested that fermentation of MC juice with lactic acid bacterium improves its inhibition of <italic>&#x003b1;</italic>-glucosidase activity [<xref rid="B58" ref-type="bibr">58</xref>], providing a new idea for researchers to acquire more efficient components from bitter melon in the future.</p></sec><sec id="sec3.2.2"><title>3.2.2. Animal Experiment</title><p>In STZ-induced diabetic rats, MC juice reduces the Na<sup>+</sup>- and K<sup>+</sup>-dependent absorption of glucose in jejunal brush border membrane vesicles by affecting PI3K [<xref rid="B30" ref-type="bibr">30</xref>]; MC powder [<xref rid="B59" ref-type="bibr">59</xref>] and fresh fruit [<xref rid="B60" ref-type="bibr">60</xref>] when given orally affect glucose absorption due to dietary fiber. Furthermore, MC powder can lower the expression of GLUT2, thus reducing the reabsorption of glucose by the kidneys and increasing the excretion of urine sugar [<xref rid="B61" ref-type="bibr">61</xref>] (<xref ref-type="fig" rid="fig2">Figure 2</xref>).</p></sec></sec><sec id="sec3.3"><title>3.3. Inhibiting Gluconeogenesis and Glycogenolysis</title><p>According to reports, MC extract treatment can inhibit glycogenolysis in liver slices in vitro and in liver tissue in ALX-induced diabetic rats [<xref rid="B32" ref-type="bibr">32</xref>]. Meanwhile, saponins from MC have the ability to promote AMPK phosphorylation, thereby preventing gluconeogenesis in the liver of diabetic mice [<xref rid="B43" ref-type="bibr">43</xref>]. Increased activation of fat 11beta-hydroxysteroid dehydrogenase type 1 (11<italic>&#x003b2;</italic>-HSD1) is currently recognized as an important cause of obesity and type 2 diabetes epidemics. An experiment in vitro with respect to the effect of MC extract on 11<italic>&#x003b2;</italic>-HSD1 indicates that the activity of 11<italic>&#x003b2;</italic>-HSD1 is inhibited in dose-dependent and selective manner, resulting in the decrease of intracellular glucocorticoids concentrations, and further inhibits phosphoenolpyruvate carboxykinase (PEPCK) [<xref rid="B62" ref-type="bibr">62</xref>]. It is also demonstrated that MC ethanol extract can inhibit hepatic glycosylation in HFD mice, and the effect is attributed to less expression of PEPCK and glucose-6-phosphatase (G-6-Pase), owing to the increase of AMPK phosphorylation and decrease of liver 11<italic>&#x003b2;</italic>-HSD1 [<xref rid="B63" ref-type="bibr">63</xref>] (<xref ref-type="fig" rid="fig3">Figure 3</xref>).</p></sec><sec id="sec3.4"><title>3.4. Protecting Islet <italic>&#x003b2;</italic> Cells</title><sec id="sec3.4.1"><title>3.4.1. Cell Experiment</title><p>Four new cucurbitane-type triterpenes derived from MC show a protective effect on H<sub>2</sub>O<sub>2</sub>-damaged pancreatic cells; in particular, the protection ratio of compounds 2 and 3 reached up to 94.85% and 92.85%, separately. It is also found that the saponin-rich part of MC motivated insulin secretion in pancreatic <italic>&#x003b2;</italic> cells of MIN6 in a concentration-dependent manner [<xref rid="B64" ref-type="bibr">64</xref>]. An experiment on the treatment of high glucose-treated RIN-m5F pancreatic <italic>&#x003b2;</italic> cells with the aqueous extract of MC shows that the survival rate of cells was significantly higher than that of untreated glucotoxic cells after 24 hours, but no protective effect was detected after 72 hours [<xref rid="B37" ref-type="bibr">37</xref>]. The underlying mechanism of this beneficial effect is still unknown. One study believes that it is attributed to the increase in the secretion of glucagon-like peptide-1 (GLP-1) which may help toward beta-cell proliferation and insulin secretion. Water extract of bitter melon stimulates the secretion of GLP-1 in the mouse enteroendocrine cell line STC-1 in a dose-dependent way. In addition, it works through certain bitter taste receptors (type 2) (TAS2R) and/or phospholipase C <italic>&#x003b2;</italic>2-signaling pathway (PLC-<italic>&#x003b2;</italic>2), and two cucurbitane triterpenoids isolated from MC display high efficacy [<xref rid="B65" ref-type="bibr">65</xref>]. Besides, it is recorded that excessive glucocorticoids regulated by 11<italic>&#x003b2;</italic>-HSD1 are involved in the beta-cell damage and impair glucose-stimulated insulin secretion (GSIS) [<xref rid="B66" ref-type="bibr">66</xref>&#x02013;<xref rid="B68" ref-type="bibr">68</xref>], while MC extracts can inhibit the activity of 11<italic>&#x003b2;</italic>-HSD1 significantly [<xref rid="B62" ref-type="bibr">62</xref>].</p></sec><sec id="sec3.4.2"><title>3.4.2. Animal Experiment</title><p>In STZ-induced diabetic mice, it has been confirmed that a polysaccharide isolated from MC (MCPIIa) [<xref rid="B69" ref-type="bibr">69</xref>] and <italic>Momordica charantia</italic> polysaccharide-chromium (III) complex (MCPIIaC) [<xref rid="B70" ref-type="bibr">70</xref>] are effective in protecting pancreatic cells and increasing plasma insulin; selenylated polysaccharide from MC can also increase insulin level [<xref rid="B71" ref-type="bibr">71</xref>]. A series of experiments on STZ-induced diabetic rats further confirmed this activity and investigated the underlying mechanism. MC juice treatment can raise the quantity of <italic>&#x003b2;</italic> cells by promoting the renewal or recovery of destroyed <italic>&#x003b2;</italic> cells [<xref rid="B72" ref-type="bibr">72</xref>], and it significantly improves insulin levels as well as the amount of insulin-positive cells per islet [<xref rid="B30" ref-type="bibr">30</xref>]. MC juice taken orally can also improve the histopathological changes of pancreas and <italic>&#x003b2;</italic> cell function percent in the way of reducing pancreatic malondialdehyde (MDA) content, increasing serum total antioxidant capacity (TAOC) and pancreatic glutathione (GSH) levels [<xref rid="B33" ref-type="bibr">33</xref>]. The results are consistent with the findings of Wang et al. who reported that <italic>Momordica charantia</italic> polysaccharide (MCP) distinctly improved antioxidant capacity by increasing superoxide dismutase (SOD) content and reducing MDA content, and therefore it mitigated the damage of pancreas caused by STZ and repaired pancreatic <italic>&#x003b2;</italic> cells [<xref rid="B43" ref-type="bibr">43</xref>]. Besides, treatment with ethanolic extract of MC almost doubles the total quantity and area of <italic>&#x003b2;</italic> cells and keeps the quantity of <italic>&#x003b2;</italic>-cell insulin granules equivalent to that of nondiabetic group [<xref rid="B73" ref-type="bibr">73</xref>]. Subchronic studies of ALX-induced diabetic rats have similar findings. A standardized ethanolic extract of MC is valid for restoring the altered histological architecture and enhancing insulin secretion of the islets of Langerhans [<xref rid="B32" ref-type="bibr">32</xref>]. The hypoglycemic effects of acetone extract [<xref rid="B74" ref-type="bibr">74</xref>] and alcoholic extract [<xref rid="B75" ref-type="bibr">75</xref>] have also been found to be closely related to the promotion of <italic>&#x003b2;</italic>-cell regeneration (<xref ref-type="fig" rid="fig4">Figure 4</xref>).</p><p>In addition, experiments pertaining to the mechanism of MC on activating <italic>&#x003b2;</italic> cells have other discoveries. An article states that MC powder can improve pancreatic function by activating pancreatic <italic>&#x003b2;</italic> cells, evidently increasing the expression of insulin and pancreatic duodenal homeobox factors-1 (Pdx1) genes [<xref rid="B61" ref-type="bibr">61</xref>]. As we know, Pdx1 is beneficial to the regulation of pancreatic development and stimulation of <italic>&#x003b2;</italic> cell growth [<xref rid="B76" ref-type="bibr">76</xref>]. One study in healthy and diabetic Wistar rats illustrates that the effect of MC aqueous extract on the elevation of <italic>&#x003b2;</italic> cell proliferation and insulin secretion is related to the elevation of GLP-1 level, and it may result from the enteroendocrine L-cell allosterism and proliferation; besides, the polar molecules of MC depolarize L cells by raising intracellular Ca<sup>2+</sup> concentration, which in turn strengthens the release of GLP-1 [<xref rid="B77" ref-type="bibr">77</xref>]. Another study suggests that water extract of bitter gourd stimulates GLP-1 and insulin secretion in mice, and the hypoglycemic effect can be revoked by GLP-1 receptor antagonist [<xref rid="B65" ref-type="bibr">65</xref>]. Subcutaneous injection with protein extract from MC fruit pulp can also lower plasma glucose and elevate insulin concentration via both insulin secretagogue and insulinomimetic activities, and this is further proved through pancreatic perfusion in situ [<xref rid="B31" ref-type="bibr">31</xref>].</p><p>All in all, the <italic>&#x003b2;</italic>-cell protection effect of MC is related to pancreatic MDA, GSH and serum TAOC, upregulation of insulin and Pdx1 genes, increased GLP-1 secretion via TAS2R, PLC-<italic>&#x003b2;</italic>2, and intracellular Ca<sup>2+</sup> concentration, as well as the inhibition of 11<italic>&#x003b2;</italic>-HSD1 (<xref ref-type="fig" rid="fig4">Figure 4</xref>).</p></sec></sec><sec id="sec3.5"><title>3.5. Antioxidation</title><sec id="sec3.5.1"><title>3.5.1. Cell Experiment</title><p>It is shown that aqueous extracts of MC pulp as well as flesh extracts are capable of preventing the accumulation of crosslinked advanced glycation end products (AGEs) and carboxymethyl lysine (CML), which is probably owing to the antioxidant characteristic, especially the total phenolic content of the extracts [<xref rid="B78" ref-type="bibr">78</xref>]. Flavonoids abstracted from ethanol-modified SC-CO<sub>2</sub> extraction method have great ability to clear 1,1-diphenyl-2-picrylhydrazyl (DPPH) free radical, which reached up to 96.14&#x02009;&#x000b1;&#x02009;1.02%, corresponding to the clearance rate of ascorbic acid at 1.2&#x02009;mg/mL [<xref rid="B79" ref-type="bibr">79</xref>]. An acid branched heteropolysaccharide derived from MC displayed free radical scavenging activity (31.9%) and ferric reducing antioxidant power (FRAP) (0.95&#x02009;mM) [<xref rid="B52" ref-type="bibr">52</xref>]. It is also found that chemical modification without changing the overall properties can effectively optimize the activity of MCP. Sulfated MCP exhibits stronger effect on anti-lipid peroxidation and superoxide anion (O<sup>2&#x02212;</sup>) scavenging. On the other hand, phosphorylated MCP shows higher antioxidant activity on both ability to scavenge hydroxyl radical (HO&#x000b7;), O<sup>2&#x02212;</sup>, and DPPH radical and the antilipid peroxidation and reduction ability [<xref rid="B80" ref-type="bibr">80</xref>]. It has been reported that choosing opportune harvest time can significantly increase the content of total anthocyanins in MC, contributing to the higher free radical scavenging and antidiabetic activities of it [<xref rid="B56" ref-type="bibr">56</xref>].</p></sec><sec id="sec3.5.2"><title>3.5.2. Animal Experiment</title><p>In STZ-induced diabetic mice, MCPIIaC strengthens the antioxidant enzyme defense system and weakens peroxidation of lipids in a dose-related manner, which indicates that the antidiabetic effect of MCPIIaC may be relevant to its antiglycation ability [<xref rid="B70" ref-type="bibr">70</xref>]. Selenylated MCP reinforces its hypoglycemic activity by increasing antioxidant enzyme activity [<xref rid="B71" ref-type="bibr">71</xref>]. MCP orally restores TAOC by improving the level of SOD and declining the level of MDA [<xref rid="B43" ref-type="bibr">43</xref>]. It is also shown that MCP treatment in diabetic rats can significantly increase GSH, SOD, and catalase (CAT) levels via heme oxygenase-1 (HO-1)/nuclear factor erythroid 2-related factor 2 (Nrf2) pathway, while it can decrease MDA in diabetic kidneys [<xref rid="B81" ref-type="bibr">81</xref>]. In addition, in high-fat-induced obese rats, allosteric MCP through <italic>Momordica charantia</italic> fermentation decreases the lipid and oxidative stress level, resulting in the remarkable reduction of insulin resistance [<xref rid="B82" ref-type="bibr">82</xref>].</p><p>What is more, it has been recorded in the literature that not only oxidative stress but also endoplasmic reticulum stress plays crucial roles in the pathogenesis of diabetes [<xref rid="B83" ref-type="bibr">83</xref>]. An article demonstrates that MC treats diabetes by ameliorating endoplasmic reticulum stress and oxidative stress [<xref rid="B84" ref-type="bibr">84</xref>]. We can see the different aspects of antioxidant effect of MC more clearly in <xref ref-type="fig" rid="fig5">Figure 5</xref>.</p></sec></sec><sec id="sec3.6"><title>3.6. Anti-Inflammation</title><sec id="sec3.6.1"><title>3.6.1. Cell Experiment</title><p>Type 2 diabetes is considered to have a chronic low-grade inflammation state, and the increase of inflammatory factors may affect insulin signal transduction, which is related to the formation of insulin resistance [<xref rid="B85" ref-type="bibr">85</xref>]. Many reports have shown that gentisic acid 5-O-<italic>&#x003b2;</italic>-d-xyloside [<xref rid="B55" ref-type="bibr">55</xref>], cucurbit type triterpenes [<xref rid="B54" ref-type="bibr">54</xref>] identified from MC, and butanol fraction of bitter gourd extract have obvious effects on inhibiting the expression of tumor necrosis factor&#x02013;<italic>&#x003b1;</italic> (TNF-<italic>&#x003b1;</italic>), IL-1<italic>&#x003b1;</italic>, IL-1<italic>&#x003b2;</italic>, IL-6, G1p2 (gene symbol of interferon, &#x02009;<italic>&#x003b1;</italic>-inducible&#x02009;protein), chemokine&#x02009; (C&#x02212;C&#x02009; motif) &#x02009;ligand&#x02009;5 (CCL5), and other inflammatory genes in lipopolysaccharide-induced RAW264.7 cell [<xref rid="B86" ref-type="bibr">86</xref>], with a significant decrease of nitric oxide (NO) in hepatocytes [<xref rid="B87" ref-type="bibr">87</xref>]. The anti-inflammatory effect of cucurbit type triterpenes is also confirmed in HepG2 cells. Seventeen cucurbitane-type triterpene glycosides (1&#x02013;17) isolated from MC evidently inhibit the activity of NF-<italic>&#x003ba;</italic>B mediated by TNF-<italic>&#x003b1;</italic>, and some also suppress inducible nitric oxide synthase (iNOS) and cyclooxygenase (COX-2) expressions and stimulate PPAR-<italic>&#x003b3;</italic> significantly [<xref rid="B88" ref-type="bibr">88</xref>, <xref rid="B89" ref-type="bibr">89</xref>] (<xref ref-type="fig" rid="fig6">Figure 6</xref>).</p></sec><sec id="sec3.6.2"><title>3.6.2. Animal Experiment</title><p>In HFD OLETF rats, MC powder significantly decreases proinflammatory cytokines (IL-6, TNF-<italic>&#x003b1;</italic>, and CCL2) in liver, muscle, and epididymal fat by preventing the phosphorylation of JNK and nuclear translocation of NF-<italic>&#x003ba;</italic>B, thus reversing the inflammation-induced changes in IRS-1 and Akt, which ameliorate glucose tolerance and insulin sensitivity [<xref rid="B36" ref-type="bibr">36</xref>]. On the other hand, in HFD obese mice, MC powder treatment exhibits an activity against the infiltration of obesity-related macrophage and mast cell and the expression of inflammatory cytokines in adipose tissue [<xref rid="B90" ref-type="bibr">90</xref>]. The ethyl acetate-soluble fraction of MC extract, containing cucurbitacin B, markedly suppresses the expression of IL-1<italic>&#x003b2;</italic> mRNA, TNF-<italic>&#x003b1;</italic> mRNA, and iNOS gene in T2DM ob/ob mouse model [<xref rid="B87" ref-type="bibr">87</xref>] (<xref ref-type="fig" rid="fig6">Figure 6</xref>). A minority of studies have also found the anti-inflammatory effect of MC in T1DM. It has been proved that this effect of MC juice is associated with the anti-inflammatory and immunosuppressive activities of T-helper 2 cell. The juice promotes the anti-inflammatory phenotype of Th2 by decreasing Th1 cytokines (IL-2, interferon-<italic>&#x003b3;</italic>) and increasing Th2 cytokines (IL-4) and IL-10 (regulatory cytokines). It exerts anti-inflammatory effects by reducing proinflammatory cytokines (IL-1, IL-6, TNF-<italic>&#x003b1;</italic>, and IL-7) and elevating anti-inflammatory cytokines (TGF-<italic>&#x003b2;</italic>, IL-10). As a result, MC juice prevents the effect of autoreactive T cells on <italic>&#x003b2;</italic> cells in T1DM rats [<xref rid="B91" ref-type="bibr">91</xref>, <xref rid="B92" ref-type="bibr">92</xref>].</p><p>Additionally, other mechanisms underlying the antidiabetic effect of MC have been investigated, especially the role of intestinal microbiota disorders in driving type 2 diabetes [<xref rid="B93" ref-type="bibr">93</xref>]. In STZ-induced diabetic rats, dried bitter gourd powder feeding can improve the diabetic status of rats, which may be attributed to high fiber content [<xref rid="B59" ref-type="bibr">59</xref>], especially pectin, a kind of soluble dietary fiber in fresh fruit. This fiber can regulate intestinal flora and increase intestinal SCFA concentration and fecal cholesterol secretion [<xref rid="B60" ref-type="bibr">60</xref>]. Studies also demonstrate that MC fermentation with <italic>Lactobacillus plantarum</italic> NCU116 optimizes the structure of polysaccharides, leading to the improvement of intestinal flora and colon SCFA production, which enhances its antidiabetic effect [<xref rid="B82" ref-type="bibr">82</xref>]. Another report reveals that MC preparation can alter the proportion of specific bacterial flora and influence the intestinal epithelial barrier and intestinal mucosal immunity, thereby adjusting inflammation levels and eventually mitigating insulin resistance and diabetes in diabetic rats. The mechanism is named as &#x0201c;Bacteria-Mucosal Immunity-Inflammation-Diabetes Axis&#x0201d; [<xref rid="B94" ref-type="bibr">94</xref>], which may be a potential insight that deserves to be explored in depth.</p><p>Over and above that, in the research carried out by Ebrahim et al., it is found that the bitter gourd fruit has the highest extractable zinc concentration, and zinc has the functions of insulin simulation and insulin-secretion promotion, as well as regulation of GLUT4 transport and glucose utilization, which conduce the hypoglycemia of MC [<xref rid="B95" ref-type="bibr">95</xref>].</p><p>Moreover, the hypoglycemic activity of different dosage forms and extraction methods of MC has been evidenced in different animal models. In the ALX-induced diabetic rat model, the water extract of MC is more effective than dried fruit powder. The former also delayed the onset of cataracts, which indicates the adaptability of MC [<xref rid="B96" ref-type="bibr">96</xref>]. An experiment, using normal and ALX-induced diabetic rabbits as subjects, demonstrates the significant and consistent hypoglycemic effect of MC [<xref rid="B97" ref-type="bibr">97</xref>]. The antihyperglycemic activity of MC peptide and its peptide analog series have been represented in STZ-induced diabetic mice [<xref rid="B98" ref-type="bibr">98</xref>], as well as MC water-soluble polysaccharide in ALX-induced diabetic mice [<xref rid="B99" ref-type="bibr">99</xref>]. Additionally, it is reported that pretreatment with MC juice succeeds in reversing the pathological damage caused by STZ in diabetic rats via controlling hyperglycemia, hyperlipidemia, and oxidative stress but fails in preventing the occurrence of disease [<xref rid="B33" ref-type="bibr">33</xref>].</p></sec></sec></sec><sec id="sec4"><title>4. Clinical Trials</title><p>As the hypoglycemic properties of MC have been generally verified in cell and animal experiments, some small-sample clinical trials have been performed. In 1993, a clinical trial was conducted in 12 male diabetic subjects with mild (postprandial blood sugar of 260&#x02009;mg%) to severe (postprandial blood sugar of 433&#x02009;mg%) degree. The result suggests that the hypoglycemic effect of MC is outstanding but cumulative and gradual. MC water extract is much better than dry powder and can delay the onset of cataracts and other secondary complications [<xref rid="B96" ref-type="bibr">96</xref>]. MC homogenized aqueous suspension treatment in 100 moderate non-insulin-dependent diabetic mellitus (NIDDM) patients results in a notable decline in postprandial and fasting blood glucose (FBG) with 86%, and 5 cases only show the reduction in FBG [<xref rid="B100" ref-type="bibr">100</xref>]. In 2004, Chinese researchers made kugua jiangtang capsule with water-soluble active ingredients of bitter gourd and applied it to 35 elderly male patients with T2DM. After one course treatment (30 days), both the blood sugar and lipid had a remarkable improvement [<xref rid="B101" ref-type="bibr">101</xref>]. In the same period, patients with T2DM in India (50&#x02013;65 years old) were treated with MC extract (CCl4&#x02009;+&#x02009;C6H6 MC soft extract) plus a half-dose oral hypoglycemic agent (metformin, glibenclamide, or a combination of both) for 7 days, and ultimately the hypoglycemic effect was greater than that of full-dose hypoglycemic drugs, indicating that MC extract has synergy with oral hypoglycemic drugs [<xref rid="B102" ref-type="bibr">102</xref>].</p><p>A randomized controlled trial (RCT) of MC and rosiglitazone treatment in NIDDM patients reveals that rosiglitazone treatment can elevate the serum sialic acid, which is associated with diabetes and complications, while MC group keeps it comparable to normal subjects [<xref rid="B103" ref-type="bibr">103</xref>]. Similarly, a 4-week, double-blind RCT evaluates the efficacy of bitter melon pulp powder and metformin in newly diagnosed T2DM patients, and, conclusively, bitter melon has moderate hypoglycemic effect [<xref rid="B104" ref-type="bibr">104</xref>]. Furthermore, a RCT comparing the different effects of bitter melon and glibenclamide concludes that the hypoglycemic effect of bitter melon is inferior to that of glibenclamide, but bitter melon can ameliorate the diabetes-related cardiovascular risk factors more effectively [<xref rid="B105" ref-type="bibr">105</xref>]. Another double-blind RCT in 24 T2DM cases illustrates that MC administration for three months lowers the HbA1c, 2 h glucose, glucose AUC, and mass index and elevates the insulin secretion obviously [<xref rid="B106" ref-type="bibr">106</xref>].</p><p>In 2012, a study focused on 42 metabolic syndrome patients reported that bitter gourd treatment for three months evidently decreased the incidence of metabolic syndrome, which is recognized for predicting T2DM, and the improvement could remain for one month after stopping supplement [<xref rid="B107" ref-type="bibr">107</xref>]. An acute experiment in prediabetic adults exhibited that acute intake of bitter melon beverage led to the reduction of postprandial glucose in 50% of the subjects [<xref rid="B108" ref-type="bibr">108</xref>]. Next year, a RCT on 52 individuals with prediabetes showed that MC intake dropped the blood glucose in participants with higher baseline FBG levels more significantly [<xref rid="B109" ref-type="bibr">109</xref>]. Accordingly, we speculate that the hypoglycemic effect of MC will be more excellent in diabetics. Over and above that, one observational study on incidence and reasons of hypoglycemia in T2DM patients suggests that natural foods accounted for 16.9% of cases, where MC accounted for 54.5%, which also proves its hypoglycemic effect indirectly [<xref rid="B110" ref-type="bibr">110</xref>].</p><p>However, there are also some studies suspecting the ability of MC to improve the disorder of glucose metabolism. In 2007, a RCT on type 2 diabetics elucidated the issue regarding the hypoglycemic effects of MC for the first time. It is concluded that the difference in average change in HbA1c between MC capsules and placebo was 0.22%, with the hypoglycemic power being lower than 11% [<xref rid="B111" ref-type="bibr">111</xref>]. Then, in 2009, a RCT in nondiabetic overweight men demonstrated that acute, single oral administration of MC powder was useless for insulin or blood glucose and energy expenditure [<xref rid="B112" ref-type="bibr">112</xref>]. Cochrane systematic reviews in 2010 [<xref rid="B113" ref-type="bibr">113</xref>] and 2012 [<xref rid="B114" ref-type="bibr">114</xref>] both reported that there was not enough evidence to suggest MC for type 2 diabetes at that time. However, a systematic review and meta-analysis in 2019 drew the opposite conclusion, but the quality of evidence was low [<xref rid="B25" ref-type="bibr">25</xref>].</p></sec><sec id="sec5"><title>5. Effects on Diabetes Complications</title><sec id="sec5.1"><title>5.1. Diabetic Microvascular Complications</title><p>In STZ-induced T2DM mice, the renoprotective nature of <italic>Momordica</italic> saponins is exerted by improving the level of uric acid and creatinine, while MCP functions mainly through enhancing antioxidant capacity [<xref rid="B43" ref-type="bibr">43</xref>]. It is also illustrated that MCP inhibits the exacerbation of diabetic nephropathy by suppressing oxidative stress and regulating HO-1/Nrf2 pathway in STZ-induced diabetic rats [<xref rid="B81" ref-type="bibr">81</xref>]. MC extract administration prolongs diabetic nephropathy via protecting kidneys from oxidative damage [<xref rid="B115" ref-type="bibr">115</xref>]. On the other hand, bitter gourd feeding controls kidney complications by means of countering the increase in the components of glycoconjugates and the decrease in kidney heparan sulfate during diabetes [<xref rid="B116" ref-type="bibr">116</xref>]. Another study observes that MC extract mitigates the apoptosis of retinal ganglion cells in T2DM rats by downregulating Bax or upregulating Bcl-2 mRNA and protein expression levels [<xref rid="B117" ref-type="bibr">117</xref>].</p></sec><sec id="sec5.2"><title>5.2. Diabetic Macrovascular Complications</title><p>Dietary MC freeze-dried powder can optimize multiple lipid parameters in rats fed with or without cholesterol-enriched diets [<xref rid="B118" ref-type="bibr">118</xref>], and it may be related to the inhibitory effect of diosgenin, dietary fiber, and phytosterols in MC on cholesterol absorption [<xref rid="B60" ref-type="bibr">60</xref>]. Besides, multiple reports have expounded the hypolipidemic activity of <italic>Momordica</italic> saponin [<xref rid="B43" ref-type="bibr">43</xref>], MC ethanol extract [<xref rid="B32" ref-type="bibr">32</xref>], and MC leaf extract [<xref rid="B119" ref-type="bibr">119</xref>]. A clinical RCT also confirms the improvement of dyslipidemia by bitter melon hot water extract [<xref rid="B120" ref-type="bibr">120</xref>]. All of the above indicate that MC has antiatherosclerosis potential. In T2DM and related cardiovascular diseases, bitter melon extract enhances cardiac function and mitigates postischemic/reperfused infarct zone, which have correlation with reduced expression of caspase-3 in heart [<xref rid="B121" ref-type="bibr">121</xref>]. It is evidenced that MC can be used to treat diabetes-associated cardiac fibrosis because of its inhibitory capacity in fibroblast proliferation and collagen synthesis, which is mediated by suppressing TGF-<italic>&#x003b2;</italic>1/Smad pathway and activating Nrf2 [<xref rid="B122" ref-type="bibr">122</xref>]. Polysaccharide from MC is discovered to have powerful angiotensin-converting enzyme inhibitory properties (94.1%) [<xref rid="B52" ref-type="bibr">52</xref>], pointing to its application in various cardiovascular complications. What is more, it is reported that nanoparticles of MC extract reduce blood viscosity in hyperglycemic individuals [<xref rid="B123" ref-type="bibr">123</xref>] and water extract of MC has inhibitory properties in AGEs accumulation and oxidative stress [<xref rid="B78" ref-type="bibr">78</xref>], which are involved in controlling diabetic complications.</p><p>In addition, findings suggest that topical application of bitter melon extract can promote the growth of granulation tissue and angiogenesis in diabetic wounds [<xref rid="B124" ref-type="bibr">124</xref>]. MC seeds have the potential to mitigate blood lipids and serum uric acid [<xref rid="B125" ref-type="bibr">125</xref>].</p></sec></sec><sec id="sec6"><title>6. Side Effects</title><p>Although many research studies show that diverse MC preparations have no significant toxic effects [<xref rid="B75" ref-type="bibr">75</xref>, <xref rid="B87" ref-type="bibr">87</xref>, <xref rid="B99" ref-type="bibr">99</xref>], there are quite a few reports illustrating the adverse effects of MC. Researchers discovered <italic>&#x003b1;</italic>-momorcharin, a kind of ribosome-inactivating protein in the seeds of MC, and it stimulated the inflammatory response of human monocytes via activating the IKK/NF-<italic>&#x00138;</italic>B and JNK pathways, which increased the risk of acquiring inflammation-related diseases for using MC [<xref rid="B126" ref-type="bibr">126</xref>]. Toxicological studies of MC on albino rats suggested that subcutaneous injection of MC ethanol extract caused abnormal breathing and heart rate after two hours, and MC juice led to acute poisoning symptoms such as acute convulsions, nervous disorders, jumping, and shortness of breath [<xref rid="B127" ref-type="bibr">127</xref>]. Besides, it is found that water extract of immature bitter gourd fruit exhibits its abortion and teratogenic properties when administered to pregnant Sprague Dawley rats [<xref rid="B128" ref-type="bibr">128</xref>]. The teratogenicity and cardiotoxicity of MC fruit and seed extracts have been characterized in zebrafish embryos [<xref rid="B129" ref-type="bibr">129</xref>]. In female Wistar rats, leaf extracts of MC, oral intake for 30 days, brought about a significant decrease in estrogen and progesterone levels, showing a dose-dependent antifertility effect [<xref rid="B130" ref-type="bibr">130</xref>]. However, in male mice, intraperitoneal administration of MC seed extracts displayed an antispermatogenic effect after 48 days [<xref rid="B131" ref-type="bibr">131</xref>]. Therefore, MC application should be recommended with caution, especially for the diabetics who are planning to be or have been pregnant.</p></sec><sec id="sec7"><title>7. Conclusion</title><p>In summary, MC is an easily available and cheap vegetable with a broad range of therapeutic activities and insignificant defects. The antidiabetic potential of MC is in line with the general pursuit of a healthy diet and represents a fresh, hopeful method to expand the scope of diabetes treatment. However, due to insufficient clinical evidence and lack of definite curative MC preparations and scientific intervention programs, its application in the field of food and pharmaceuticals is still in its infancy, and it is far from being fully utilized in diabetic patients. Therefore, it is necessary to explore further how to apply the research results to clinical practice reasonably and sustainably to create a better future for people with diabetes.</p></sec></body><back><ack><title>Acknowledgments</title><p>This work was supported by the National Key R&#x00026;D Program of China (grant no. 2018YFC1704202) and the National Natural Science Foundation of China (nos. 81874382, 81904158, and 81904011).</p></ack><glossary><title>Abbreviations</title><def-list><def-item><term>MC:</term><def><p>
<italic>Momordica charantia</italic>
</p></def></def-item><def-item><term>DM:</term><def><p>Diabetes mellitus</p></def></def-item><def-item><term>T1DM:</term><def><p>Type 1 diabetes mellitus</p></def></def-item><def-item><term>T2DM:</term><def><p>Type 2 diabetes mellitus</p></def></def-item><def-item><term>GLUT:</term><def><p>Translocation of glucose transporter</p></def></def-item><def-item><term>IR:</term><def><p>Insulin receptor</p></def></def-item><def-item><term>mcIRBP:</term><def><p>Insulin receptor-binding protein from <italic>Momordica charantia</italic></p></def></def-item><def-item><term>AMPK:</term><def><p>Adenosine 5&#x02032;-monophosphate-activated protein kinase</p></def></def-item><def-item><term>IRS-1:</term><def><p>Insulin receptor substrate-1</p></def></def-item><def-item><term>Akt:</term><def><p>Protein kinase B</p></def></def-item><def-item><term>GSK-3:</term><def><p>Glycogen synthase kinase 3</p></def></def-item><def-item><term>PPAR:</term><def><p>Peroxisome proliferator-activated receptor</p></def></def-item><def-item><term>HFD:</term><def><p>High-fat diet</p></def></def-item><def-item><term>STZ:</term><def><p>Streptozocin</p></def></def-item><def-item><term>ALX:</term><def><p>Alloxan</p></def></def-item><def-item><term>HbA1c:</term><def><p>Hemoglobin A1c</p></def></def-item><def-item><term>FBG:</term><def><p>Fasting blood glucose</p></def></def-item><def-item><term>NIDDM:</term><def><p>Non-insulin-dependent diabetic mellitus</p></def></def-item><def-item><term>PEPCK:</term><def><p>Phosphoenolpyruvate carboxykinase</p></def></def-item><def-item><term>G-6-Pase:</term><def><p>Glucose-6-phosphatase</p></def></def-item><def-item><term>ACO:</term><def><p>Acyl-CoA oxidase</p></def></def-item><def-item><term>MCP:</term><def><p>
<italic>Momordica charantia</italic> polysaccharide</p></def></def-item><def-item><term>MCPIIaC:</term><def><p>
<italic>Momordica charantia</italic> polysaccharide-chromium (III) complex</p></def></def-item><def-item><term>MDA:</term><def><p>Malondialdehyde</p></def></def-item><def-item><term>TAOC:</term><def><p>Total antioxidant capacity</p></def></def-item><def-item><term>GSH:</term><def><p>Glutathione</p></def></def-item><def-item><term>SOD:</term><def><p>Superoxide dismutase</p></def></def-item><def-item><term>AGEs:</term><def><p>Advanced glycation end products</p></def></def-item><def-item><term>CML:</term><def><p>Carboxymethyl lysine</p></def></def-item><def-item><term>DPPH:</term><def><p>1,1-Diphenyl-2-picrylhydrazyl</p></def></def-item><def-item><term>SOCS-3:</term><def><p>Suppressors-of-cytokine-signaling 3</p></def></def-item><def-item><term>JNK c:</term><def><p>Jun N-terminal kinase</p></def></def-item><def-item><term>11<italic>&#x003b2;</italic>-HSD:</term><def><p>11beta-hydroxysteroid dehydrogenase type 1</p></def></def-item><def-item><term>GLP-1:</term><def><p>Glucagon-like peptide-1</p></def></def-item><def-item><term>PDX-1:</term><def><p>Pancreatic duodenal homeobox factors-1</p></def></def-item><def-item><term>HO-1:</term><def><p>Heme oxygenase-1</p></def></def-item><def-item><term>Nrf2:</term><def><p>Nuclear factor erythroid 2-related factor 2</p></def></def-item><def-item><term>TNF-<italic>&#x003b1;</italic>:</term><def><p>Tumor necrosis factor&#x02013;<italic>&#x003b1;</italic></p></def></def-item><def-item><term>G1p2:</term><def><p>Gene symbol of interferon</p></def></def-item><def-item><term>&#x02009;<italic>&#x003b1;</italic>:</term><def><p>Inducible&#x02009;protein</p></def></def-item><def-item><term>CCL:</term><def><p>Chemokine &#x02009;(C&#x02212;C motif)&#x02009; ligand&#x02009;</p></def></def-item><def-item><term>NO:</term><def><p>Nitric oxide</p></def></def-item><def-item><term>TGF-<italic>&#x003b2;</italic>:</term><def><p>Transforming growth factor-<italic>&#x003b2;</italic></p></def></def-item><def-item><term>iNOS:</term><def><p>Inducible nitric oxide synthase</p></def></def-item><def-item><term>COX-2:</term><def><p>Cyclooxygenase-2</p></def></def-item><def-item><term>GS:</term><def><p>Glycogen synthase</p></def></def-item><def-item><term>TAS2R:</term><def><p>Bitter taste receptors, type 2</p></def></def-item><def-item><term>PLC-<italic>&#x003b2;</italic>2:</term><def><p>Phospholipase C <italic>&#x003b2;</italic>2-signaling pathway</p></def></def-item><def-item><term>GSIS:</term><def><p>Glucose-stimulated insulin secretion</p></def></def-item><def-item><term>FRAP:</term><def><p>Ferric reducing antioxidant power</p></def></def-item><def-item><term>O<sup>2-</sup>:</term><def><p>Superoxide anion</p></def></def-item><def-item><term>HO:</term><def><p>Hydroxyl radical</p></def></def-item><def-item><term>CAT:</term><def><p>Catalase</p></def></def-item><def-item><term>SGLT:</term><def><p>Sodium glucose cotransporter</p></def></def-item><def-item><term>Na+/K&#x02009;+&#x02009;ATPase:</term><def><p>Na+, K+ stimulated adenosine triphosphatase.</p></def></def-item></def-list></glossary><sec sec-type="data-availability"><title>Data Availability</title><p>No data were used to support this study.</p></sec><sec sec-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></sec><sec><title>Authors' Contributions</title><p>Hui Dong and Fuer Lu designed the study; Zhuo Liu reviewed the research and drafted the manuscript; Jing Gong and Wenya Huang revised the figures and manuscript critically. All authors approved the final version of the manuscript.</p></sec><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><collab>American Diabetes Association</collab><article-title>Diagnosis and classification of diabetes mellitus</article-title><source><italic toggle="yes">Diabetes Care</italic></source><year>2010</year><volume>33</volume><issue>Suppl 1</issue><fpage>S62</fpage><lpage>S69</lpage><pub-id pub-id-type="doi">10.2337/dc14-S081</pub-id><pub-id pub-id-type="other">2-s2.0-84892659350</pub-id><pub-id pub-id-type="pmid">20042775</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="book"><collab>World Health Organization</collab><source><italic toggle="yes">Global Report on Diabetes</italic></source><year>2016</year><publisher-loc>Geneva, Switzerland</publisher-loc><publisher-name>World Health Organization</publisher-name></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><collab>American Diabetes Association</collab><article-title>2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2018</article-title><source><italic toggle="yes">Diabetes Care</italic></source><year>2018</year><volume>41</volume><issue>Suppl 1</issue><fpage>S13</fpage><lpage>S27</lpage><pub-id pub-id-type="doi">10.2337/dc18-S002</pub-id><pub-id pub-id-type="other">2-s2.0-85039703274</pub-id><pub-id pub-id-type="pmid">29222373</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarwar</surname><given-names>N.</given-names></name><name><surname>Gao</surname><given-names>P.</given-names></name><name><surname>Seshasai</surname><given-names>S. R. K.</given-names></name><etal/></person-group><article-title>Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies</article-title><source><italic toggle="yes">Lancet (London, England)</italic></source><year>2010</year><volume>375</volume><issue>9733</issue><fpage>2215</fpage><lpage>2222</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(10)60484-9</pub-id><pub-id pub-id-type="other">2-s2.0-77953821528</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Markoulli</surname><given-names>M.</given-names></name><name><surname>Flanagan</surname><given-names>J.</given-names></name><name><surname>Tummanapalli</surname><given-names>S. S.</given-names></name><name><surname>Wu</surname><given-names>J.</given-names></name><name><surname>Willcox</surname><given-names>M.</given-names></name></person-group><article-title>The impact of diabetes on corneal nerve morphology and ocular surface integrity</article-title><source><italic toggle="yes">The Ocular Surface</italic></source><year>2018</year><volume>16</volume><issue>1</issue><fpage>45</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1016/j.jtos.2017.10.006</pub-id><pub-id pub-id-type="other">2-s2.0-85033584232</pub-id><pub-id pub-id-type="pmid">29113918</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rojas</surname><given-names>D. R.</given-names></name><name><surname>Kuner</surname><given-names>R.</given-names></name><name><surname>Agarwal</surname><given-names>N.</given-names></name></person-group><article-title>Metabolomic signature of type 1 diabetes-induced sensory loss and nerve damage in diabetic neuropathy</article-title><source><italic toggle="yes">Journal of Molecular Medicine</italic></source><year>2019</year><volume>97</volume><issue>6</issue><fpage>845</fpage><lpage>854</lpage><pub-id pub-id-type="doi">10.1007/s00109-019-01781-1</pub-id><pub-id pub-id-type="other">2-s2.0-85064433749</pub-id><pub-id pub-id-type="pmid">30949723</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zamfirov</surname><given-names>K.</given-names></name><name><surname>Philippe</surname><given-names>J.</given-names></name></person-group><article-title>Musculoskeletal complications in diabetes mellitus</article-title><source><italic toggle="yes">Revue M&#x000e9;dicale Suisse</italic></source><year>2017</year><volume>13</volume><issue>560</issue><fpage>917</fpage><lpage>921</lpage><pub-id pub-id-type="pmid">28727360</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koye</surname><given-names>D. N.</given-names></name><name><surname>Magliano</surname><given-names>D. J.</given-names></name><name><surname>Nelson</surname><given-names>R. G.</given-names></name><name><surname>Pavkov</surname><given-names>M. E.</given-names></name></person-group><article-title>The global epidemiology of diabetes and kidney disease</article-title><source><italic toggle="yes">Advances in Chronic Kidney Disease</italic></source><year>2018</year><volume>25</volume><issue>2</issue><fpage>121</fpage><lpage>132</lpage><pub-id pub-id-type="doi">10.1053/j.ackd.2017.10.011</pub-id><pub-id pub-id-type="other">2-s2.0-85044100927</pub-id><pub-id pub-id-type="pmid">29580576</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bourne</surname><given-names>R. R. A.</given-names></name><name><surname>Stevens</surname><given-names>G. A.</given-names></name><name><surname>White</surname><given-names>R. A.</given-names></name><etal/></person-group><article-title>Causes of vision loss worldwide, 1990-2010: a systematic analysis</article-title><source><italic toggle="yes">The Lancet Global Health</italic></source><year>2013</year><volume>1</volume><issue>6</issue><fpage>e339</fpage><lpage>e349</lpage><pub-id pub-id-type="doi">10.1016/s2214-109x(13)70113-x</pub-id><pub-id pub-id-type="other">2-s2.0-84888345347</pub-id><pub-id pub-id-type="pmid">25104599</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>&#x0015a;wi&#x00105;toniowska</surname><given-names>N.</given-names></name><name><surname>Sarzy&#x00144;ska</surname><given-names>K.</given-names></name><name><surname>Szyma&#x00144;ska-Chabowska</surname><given-names>A.</given-names></name><name><surname>Jankowska-Pola&#x00144;ska</surname><given-names>B.</given-names></name></person-group><article-title>The role of education in type 2 diabetes treatment</article-title><source><italic toggle="yes">Diabetes Research and Clinical Practice</italic></source><year>2019</year><volume>151</volume><fpage>237</fpage><lpage>246</lpage><pub-id pub-id-type="doi">10.1016/j.diabres.2019.04.004</pub-id><pub-id pub-id-type="other">2-s2.0-85065414984</pub-id><pub-id pub-id-type="pmid">31063855</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thent</surname><given-names>Z. C.</given-names></name><name><surname>Das</surname><given-names>S.</given-names></name><name><surname>Zaidun</surname><given-names>N. H.</given-names></name></person-group><article-title>Emerging trends on drug delivery strategy of momordica charantia against diabetes and its complications</article-title><source><italic toggle="yes">Current Drug Delivery</italic></source><year>2018</year><volume>15</volume><issue>4</issue><fpage>453</fpage><lpage>460</lpage><pub-id pub-id-type="doi">10.2174/1567201814666170525122224</pub-id><pub-id pub-id-type="other">2-s2.0-85047808822</pub-id><pub-id pub-id-type="pmid">28545355</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Furman</surname><given-names>B. L.</given-names></name><name><surname>Candasamy</surname><given-names>M.</given-names></name><name><surname>Bhattamisra</surname><given-names>S. K.</given-names></name><name><surname>Veettil</surname><given-names>S. K.</given-names></name></person-group><article-title>Reduction of blood glucose by plant extracts and their use in the treatment of diabetes mellitus; discrepancies in effectiveness between animal and human studies</article-title><source><italic toggle="yes">Journal of Ethnopharmacology</italic></source><year>2020</year><volume>247</volume><pub-id pub-id-type="publisher-id">112264</pub-id><pub-id pub-id-type="doi">10.1016/j.jep.2019.112264</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palamthodi</surname><given-names>S.</given-names></name><name><surname>Lele</surname><given-names>S. S.</given-names></name></person-group><article-title>Nutraceutical applications of gourd family vegetables: benincasa hispida, Lagenaria siceraria and Momordica charantia</article-title><source><italic toggle="yes">Biomedicine &#x00026; Preventive Nutrition</italic></source><year>2014</year><volume>4</volume><issue>1</issue><fpage>15</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1016/j.bionut.2013.03.004</pub-id><pub-id pub-id-type="other">2-s2.0-84894068905</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perez</surname><given-names>J. L.</given-names></name><name><surname>Jayaprakasha</surname><given-names>G. K.</given-names></name><name><surname>Crosby</surname><given-names>K.</given-names></name><name><surname>Patil</surname><given-names>B. S.</given-names></name></person-group><article-title>Evaluation of bitter melon (Momordica charantia) cultivars grown in Texas and levels of various phytonutrients</article-title><source><italic toggle="yes">Journal of the Science of Food and Agriculture</italic></source><year>2019</year><volume>99</volume><issue>1</issue><fpage>379</fpage><lpage>390</lpage><pub-id pub-id-type="doi">10.1002/jsfa.9199</pub-id><pub-id pub-id-type="other">2-s2.0-85052485630</pub-id><pub-id pub-id-type="pmid">29888551</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parvathi</surname><given-names>S.</given-names></name><name><surname>Kumar</surname><given-names>V. J. F.</given-names></name></person-group><article-title>Studies on chemical composition and utilization of the wild edible vegetable athalakkai (Momordica tuberosa)</article-title><source><italic toggle="yes">Plant Foods for Human Nutrition</italic></source><year>2002</year><volume>57</volume><issue>3/4</issue><fpage>215</fpage><lpage>222</lpage><pub-id pub-id-type="doi">10.1023/a:1021884406024</pub-id><pub-id pub-id-type="other">2-s2.0-0036770474</pub-id><pub-id pub-id-type="pmid">12602930</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jia</surname><given-names>S.</given-names></name><name><surname>Shen</surname><given-names>M.</given-names></name><name><surname>Zhang</surname><given-names>F.</given-names></name><name><surname>Xie</surname><given-names>J.</given-names></name></person-group><article-title>Recent advances in momordica charantia: functional components and biological activities</article-title><source><italic toggle="yes">International Journal of Molecular Sciences</italic></source><year>2017</year><volume>18</volume><issue>12</issue><fpage>p. 2555</fpage><pub-id pub-id-type="doi">10.3390/ijms18122555</pub-id><pub-id pub-id-type="other">2-s2.0-85036544468</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsiao</surname><given-names>P.-C.</given-names></name><name><surname>Liaw</surname><given-names>C.-C.</given-names></name><name><surname>Hwang</surname><given-names>S.-Y.</given-names></name><etal/></person-group><article-title>Antiproliferative and hypoglycemic cucurbitane-type glycosides from the fruits of Momordica charantia</article-title><source><italic toggle="yes">Journal of Agricultural and Food Chemistry</italic></source><year>2013</year><volume>61</volume><issue>12</issue><fpage>2979</fpage><lpage>2986</lpage><pub-id pub-id-type="doi">10.1021/jf3041116</pub-id><pub-id pub-id-type="other">2-s2.0-84875736736</pub-id><pub-id pub-id-type="pmid">23432055</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>S. H.</given-names></name><name><surname>Yi</surname><given-names>Y. S.</given-names></name><name><surname>Kim</surname><given-names>M. Y.</given-names></name><name><surname>Cho</surname><given-names>J. Y.</given-names></name></person-group><article-title>Antioxidative and antimelanogenesis effect of momordica charantia methanol extract</article-title><source><italic toggle="yes">Evidence-based Complementary and Alternative Medicine</italic></source><year>2019</year><volume>2019</volume><fpage>11</fpage><pub-id pub-id-type="publisher-id">5091534</pub-id><pub-id pub-id-type="doi">10.1155/2019/5091534</pub-id><pub-id pub-id-type="other">2-s2.0-85066108719</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Yang</surname><given-names>G.</given-names></name><name><surname>Ho</surname><given-names>C.-T.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name></person-group><article-title>Momordica charantia: a popular health-promoting vegetable with multifunctionality</article-title><source><italic toggle="yes">Food &#x00026; Function</italic></source><year>2017</year><volume>8</volume><issue>5</issue><fpage>1749</fpage><lpage>1762</lpage><pub-id pub-id-type="doi">10.1039/c6fo01812b</pub-id><pub-id pub-id-type="other">2-s2.0-85021813967</pub-id><pub-id pub-id-type="pmid">28474032</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rao</surname><given-names>C. V.</given-names></name></person-group><article-title>Immunomodulatory effects of momordica charantia extract in the prevention of oral cancer</article-title><source><italic toggle="yes">Cancer Prevention Research</italic></source><year>2018</year><volume>11</volume><issue>4</issue><fpage>185</fpage><lpage>186</lpage><pub-id pub-id-type="doi">10.1158/1940-6207.capr-17-0379</pub-id><pub-id pub-id-type="other">2-s2.0-85047751461</pub-id><pub-id pub-id-type="pmid">29559516</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>M.</given-names></name><name><surname>Kim</surname><given-names>E. K.</given-names></name><name><surname>Choi</surname><given-names>Y. J.</given-names></name><name><surname>Tang</surname><given-names>Y.</given-names></name><name><surname>Moon</surname><given-names>S. H.</given-names></name></person-group><article-title>The role of momordica charantia in resisting obesity</article-title><source><italic toggle="yes">International Journal of Environmental Research and Public Health</italic></source><year>2019</year><volume>16</volume><issue>18</issue><fpage>p. 3251</fpage><pub-id pub-id-type="doi">10.3390/ijerph16183251</pub-id><pub-id pub-id-type="other">2-s2.0-85071766348</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>E. F.</given-names></name><name><surname>Ng</surname><given-names>T. B.</given-names></name></person-group><article-title>The bitter fruit with sweet health benefits: a comprehensive synopsis of recent research progress on medicinal properties of momordica charantia</article-title><source><italic toggle="yes">Antitumor Potential and other Emerging Medicinal Properties of Natural Compounds</italic></source><year>2013</year><publisher-loc>Dordrecht, Netherlands</publisher-loc><publisher-name>Springer</publisher-name><fpage>315</fpage><lpage>334</lpage><pub-id pub-id-type="doi">10.1007/978-94-007-6214-5_21</pub-id><pub-id pub-id-type="other">2-s2.0-84917686290</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mootoosamy</surname><given-names>A.</given-names></name><name><surname>Fawzi Mahomoodally</surname><given-names>M.</given-names></name></person-group><article-title>Ethnomedicinal application of native remedies used against diabetes and related complications in Mauritius</article-title><source><italic toggle="yes">Journal of Ethnopharmacology</italic></source><year>2014</year><volume>151</volume><issue>1</issue><fpage>413</fpage><lpage>444</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2013.10.069</pub-id><pub-id pub-id-type="other">2-s2.0-84891496535</pub-id><pub-id pub-id-type="pmid">24231070</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yald&#x00131;z</surname><given-names>G.</given-names></name><name><surname>Sekeroglu</surname><given-names>N.</given-names></name><name><surname>Kulak</surname><given-names>M.</given-names></name><name><surname>Demirkol</surname><given-names>G.</given-names></name></person-group><article-title>Antimicrobial activity and agricultural properties of bitter melon (Momordica charantia L.) grown in northern parts of Turkey: a case study for adaptation</article-title><source><italic toggle="yes">Natural Product Research</italic></source><year>2015</year><volume>29</volume><issue>6</issue><fpage>543</fpage><lpage>545</lpage><pub-id pub-id-type="doi">10.1080/14786419.2014.949706</pub-id><pub-id pub-id-type="other">2-s2.0-84921374021</pub-id><pub-id pub-id-type="pmid">25141891</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peter</surname><given-names>E. L.</given-names></name><name><surname>Kasali</surname><given-names>F. M.</given-names></name><name><surname>Deyno</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Momordica charantia L. lowers elevated glycaemia in type 2 diabetes mellitus patients: systematic review and meta-analysis</article-title><source><italic toggle="yes">Journal of Ethnopharmacology</italic></source><year>2019</year><volume>231</volume><fpage>311</fpage><lpage>324</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2018.10.033</pub-id><pub-id pub-id-type="other">2-s2.0-85057524027</pub-id><pub-id pub-id-type="pmid">30385422</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lo</surname><given-names>H.-Y.</given-names></name><name><surname>Li</surname><given-names>C.-C.</given-names></name><name><surname>Chen</surname><given-names>F.-Y.</given-names></name><name><surname>Chen</surname><given-names>J.-C.</given-names></name><name><surname>Hsiang</surname><given-names>C.-Y.</given-names></name><name><surname>Ho</surname><given-names>T.-Y.</given-names></name></person-group><article-title>Gastro-resistant insulin receptor-binding peptide from momordica charantia improved the glucose tolerance in streptozotocin-induced diabetic mice via insulin receptor signaling pathway</article-title><source><italic toggle="yes">Journal of Agricultural and Food Chemistry</italic></source><year>2017</year><volume>65</volume><issue>42</issue><fpage>9266</fpage><lpage>9274</lpage><pub-id pub-id-type="doi">10.1021/acs.jafc.7b03583</pub-id><pub-id pub-id-type="other">2-s2.0-85032203132</pub-id><pub-id pub-id-type="pmid">28994284</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lo</surname><given-names>H.-Y.</given-names></name><name><surname>Ho</surname><given-names>T.-Y.</given-names></name><name><surname>Li</surname><given-names>C.-C.</given-names></name><name><surname>Chen</surname><given-names>J.-C.</given-names></name><name><surname>Liu</surname><given-names>J.-J.</given-names></name><name><surname>Hsiang</surname><given-names>C.-Y.</given-names></name></person-group><article-title>A novel insulin receptor-binding protein from Momordica charantia enhances glucose uptake and glucose clearance in vitro and in vivo through triggering insulin receptor signaling pathway</article-title><source><italic toggle="yes">Journal of Agricultural and Food Chemistry</italic></source><year>2014</year><volume>62</volume><issue>36</issue><fpage>8952</fpage><lpage>8961</lpage><pub-id pub-id-type="doi">10.1021/jf5002099</pub-id><pub-id pub-id-type="other">2-s2.0-84907164545</pub-id><pub-id pub-id-type="pmid">25144709</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>C.-I.</given-names></name><name><surname>Tseng</surname><given-names>H.-I.</given-names></name><name><surname>Liao</surname><given-names>Y.-W.</given-names></name><etal/></person-group><article-title>In vivo and in vitro studies to identify the hypoglycaemic constituents of Momordica charantia wild variant WB24</article-title><source><italic toggle="yes">Food Chemistry</italic></source><year>2011</year><volume>125</volume><issue>2</issue><fpage>521</fpage><lpage>528</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2010.09.043</pub-id><pub-id pub-id-type="other">2-s2.0-78049428076</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>J.-H.</given-names></name><name><surname>Tuan</surname><given-names>N. Q.</given-names></name><name><surname>Park</surname><given-names>M.-H.</given-names></name><etal/></person-group><article-title>Cucurbitane triterpenoids from the fruits of momordica charantia improve insulin sensitivity and glucose homeostasis in streptozotocin-induced diabetic mice</article-title><source><italic toggle="yes">Molecular Nutrition &#x00026; Food Research</italic></source><year>2018</year><volume>62</volume><issue>7</issue><pub-id pub-id-type="publisher-id">e1700769</pub-id><pub-id pub-id-type="doi">10.1002/mnfr.201700769</pub-id><pub-id pub-id-type="other">2-s2.0-85044788890</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmed</surname><given-names>I.</given-names></name><name><surname>Adeghate</surname><given-names>E.</given-names></name><name><surname>Cummings</surname><given-names>E.</given-names></name><name><surname>Sharma</surname><given-names>A. K.</given-names></name><name><surname>Singh</surname><given-names>J.</given-names></name></person-group><article-title>Beneficial effects and mechanism of action of Momordica charantia juice in the treatment of streptozotocin-induced diabetes mellitus in rat</article-title><source><italic toggle="yes">Molecular and Cellular Biochemistry</italic></source><year>2004</year><volume>261</volume><issue>1</issue><fpage>63</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1023/b:mcbi.0000028738.95518.90</pub-id><pub-id pub-id-type="other">2-s2.0-3442899940</pub-id><pub-id pub-id-type="pmid">15362486</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yibchok-Anun</surname><given-names>S.</given-names></name><name><surname>Adisakwattana</surname><given-names>S.</given-names></name><name><surname>Yao</surname><given-names>C. Y.</given-names></name><name><surname>Sangvanich</surname><given-names>P.</given-names></name><name><surname>Roengsumran</surname><given-names>S.</given-names></name><name><surname>Hsu</surname><given-names>W. H.</given-names></name></person-group><article-title>Slow acting protein extract from fruit pulp of Momordica charantia with insulin secretagogue and insulinomimetic activities</article-title><source><italic toggle="yes">Biological &#x00026; Pharmaceutical Bulletin</italic></source><year>2006</year><volume>29</volume><issue>6</issue><fpage>1126</fpage><lpage>1131</lpage><pub-id pub-id-type="doi">10.1248/bpb.29.1126</pub-id><pub-id pub-id-type="other">2-s2.0-33744917512</pub-id><pub-id pub-id-type="pmid">16755004</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandes</surname><given-names>N. P.</given-names></name><name><surname>Lagishetty</surname><given-names>C. V.</given-names></name><name><surname>Panda</surname><given-names>V. S.</given-names></name><name><surname>Naik</surname><given-names>S. R.</given-names></name></person-group><article-title>An experimental evaluation of the antidiabetic and antilipidemic properties of a standardized Momordica charantia fruit extract</article-title><source><italic toggle="yes">BMC Complementary and Alternative Medicine</italic></source><year>2007</year><volume>7</volume><issue>1</issue><pub-id pub-id-type="doi">10.1186/1472-6882-7-29</pub-id><pub-id pub-id-type="other">2-s2.0-35748941961</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahmoud</surname><given-names>M. F.</given-names></name><name><surname>El Ashry</surname><given-names>F. E. Z. Z.</given-names></name><name><surname>El Maraghy</surname><given-names>N. N.</given-names></name><name><surname>Fahmy</surname><given-names>A.</given-names></name></person-group><article-title>Studies on the antidiabetic activities of Momordica charantia fruit juice in streptozotocin-induced diabetic rats</article-title><source><italic toggle="yes">Pharmaceutical Biology</italic></source><year>2017</year><volume>55</volume><issue>1</issue><fpage>758</fpage><lpage>765</lpage><pub-id pub-id-type="doi">10.1080/13880209.2016.1275026</pub-id><pub-id pub-id-type="other">2-s2.0-85021851927</pub-id><pub-id pub-id-type="pmid">28064559</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hazarika</surname><given-names>R.</given-names></name><name><surname>Parida</surname><given-names>P.</given-names></name><name><surname>Neog</surname><given-names>B.</given-names></name><name><surname>Yadav</surname><given-names>R.</given-names></name></person-group><article-title>Binding Energy calculation of GSK-3 protein of Human against some anti-diabetic compounds of Momordica charantia linn (Bitter melon)</article-title><source><italic toggle="yes">Bioinformation</italic></source><year>2012</year><volume>8</volume><issue>6</issue><fpage>251</fpage><lpage>254</lpage><pub-id pub-id-type="doi">10.6026/97320630008251</pub-id><pub-id pub-id-type="pmid">22493531</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>C.</given-names></name><name><surname>Yu</surname><given-names>H.</given-names></name><name><surname>Xiao</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name></person-group><article-title>Momordica charantia extracts ameliorate insulin resistance by regulating the expression of socs-3 and jnk in type 2 diabetes mellitus rats</article-title><source><italic toggle="yes">Pharmaceutical Biology</italic></source><year>2017</year><volume>55</volume><issue>1</issue><fpage>2170</fpage><lpage>2177</lpage><pub-id pub-id-type="doi">10.1080/13880209.2017.1396350</pub-id><pub-id pub-id-type="other">2-s2.0-85049409746</pub-id><pub-id pub-id-type="pmid">29110587</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>S. J.</given-names></name><name><surname>Choi</surname><given-names>J. M.</given-names></name><name><surname>Park</surname><given-names>S. E.</given-names></name><etal/></person-group><article-title>Preventive effects of bitter melon (Momordica charantia) against insulin resistance and diabetes are associated with the inhibition of NF-<italic>&#x003ba;</italic>B and JNK pathways in high-fat-fed OLETF rats</article-title><source><italic toggle="yes">The Journal of Nutritional Biochemistry</italic></source><year>2015</year><volume>26</volume><issue>3</issue><fpage>234</fpage><lpage>240</lpage><pub-id pub-id-type="doi">10.1016/j.jnutbio.2014.10.010</pub-id><pub-id pub-id-type="other">2-s2.0-84927635080</pub-id><pub-id pub-id-type="pmid">25488547</pub-id></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H.-Y.</given-names></name><name><surname>Kan</surname><given-names>W.-C.</given-names></name><name><surname>Cheng</surname><given-names>T.-J.</given-names></name><name><surname>Yu</surname><given-names>S.-H.</given-names></name><name><surname>Chang</surname><given-names>L.-H.</given-names></name><name><surname>Chuu</surname><given-names>J.-J.</given-names></name></person-group><article-title>Differential anti-diabetic effects and mechanism of action of charantin-rich extract of Taiwanese Momordica charantia between type 1 and type 2 diabetic mice</article-title><source><italic toggle="yes">Food and Chemical Toxicology</italic></source><year>2014</year><volume>69</volume><fpage>347</fpage><lpage>356</lpage><pub-id pub-id-type="doi">10.1016/j.fct.2014.04.008</pub-id><pub-id pub-id-type="other">2-s2.0-84901416409</pub-id><pub-id pub-id-type="pmid">24751968</pub-id></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harinantenaina</surname><given-names>L.</given-names></name><name><surname>Tanaka</surname><given-names>M.</given-names></name><name><surname>Takaoka</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Momordica charantia constituents and antidiabetic screening of the isolated major compounds</article-title><source><italic toggle="yes">Chemical &#x00026; Pharmaceutical Bulletin</italic></source><year>2006</year><volume>54</volume><issue>7</issue><fpage>1017</fpage><lpage>1021</lpage><pub-id pub-id-type="doi">10.1248/cpb.54.1017</pub-id><pub-id pub-id-type="other">2-s2.0-33745685683</pub-id><pub-id pub-id-type="pmid">16819222</pub-id></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>B.</given-names></name><name><surname>Ji</surname><given-names>M.</given-names></name><name><surname>Liu</surname><given-names>W.</given-names></name><etal/></person-group><article-title>Antidiabetic activities of a cucurbitane-type triterpenoid compound from Momordica charantia in alloxan-induced diabetic mice</article-title><source><italic toggle="yes">Molecular Medicine Reports</italic></source><year>2016</year><volume>14</volume><issue>5</issue><fpage>4865</fpage><lpage>4872</lpage><pub-id pub-id-type="doi">10.3892/mmr.2016.5800</pub-id><pub-id pub-id-type="other">2-s2.0-84992323163</pub-id><pub-id pub-id-type="pmid">27748816</pub-id></element-citation></ref><ref id="B40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miura</surname><given-names>T.</given-names></name><name><surname>Kawata</surname><given-names>T.</given-names></name><name><surname>Takagi</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Effect of Momordica charantia on adenosine monophosphate-activated protein kinase in genetically type 2 diabetic mice muscle</article-title><source><italic toggle="yes">Journal of Health Science</italic></source><year>2009</year><volume>55</volume><issue>5</issue><fpage>805</fpage><lpage>808</lpage><pub-id pub-id-type="doi">10.1248/jhs.55.805</pub-id><pub-id pub-id-type="other">2-s2.0-70350231756</pub-id></element-citation></ref><ref id="B41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaturvedi</surname><given-names>P.</given-names></name></person-group><article-title>Antidiabetic potentials ofMomordica charantia: multiple mechanisms behind the effects</article-title><source><italic toggle="yes">Journal of Medicinal Food</italic></source><year>2012</year><volume>15</volume><issue>2</issue><fpage>101</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.1089/jmf.2010.0258</pub-id><pub-id pub-id-type="other">2-s2.0-84856295936</pub-id><pub-id pub-id-type="pmid">22191631</pub-id></element-citation></ref><ref id="B42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>L. L. Y.</given-names></name><name><surname>Chen</surname><given-names>Q.</given-names></name><name><surname>Go</surname><given-names>A. G. G.</given-names></name><name><surname>Lam</surname><given-names>E. K. Y.</given-names></name><name><surname>Li</surname><given-names>E. T. S.</given-names></name></person-group><article-title>Reduced adiposity in bitter melon (Momordica charantia)-fed rats is associated with increased lipid oxidative enzyme activities and uncoupling protein expression</article-title><source><italic toggle="yes">The Journal of Nutrition</italic></source><year>2005</year><volume>135</volume><issue>11</issue><fpage>2517</fpage><lpage>2523</lpage><pub-id pub-id-type="doi">10.1093/jn/135.11.2517</pub-id><pub-id pub-id-type="pmid">16251604</pub-id></element-citation></ref><ref id="B43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Wu</surname><given-names>X.</given-names></name><name><surname>Shi</surname><given-names>F.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name></person-group><article-title>Comparison of antidiabetic effects of saponins and polysaccharides from Momordica charantia L. in STZ-induced type 2 diabetic mice</article-title><source><italic toggle="yes">Biomedicine &#x00026; Pharmacotherapy</italic></source><year>2019</year><volume>109</volume><fpage>744</fpage><lpage>750</lpage><pub-id pub-id-type="doi">10.1016/j.biopha.2018.09.098</pub-id><pub-id pub-id-type="other">2-s2.0-85056192305</pub-id><pub-id pub-id-type="pmid">30551527</pub-id></element-citation></ref><ref id="B44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ha</surname><given-names>J.</given-names></name><name><surname>Guan</surname><given-names>K.-L.</given-names></name><name><surname>Kim</surname><given-names>J.</given-names></name></person-group><article-title>AMPK and autophagy in glucose/glycogen metabolism</article-title><source><italic toggle="yes">Molecular Aspects of Medicine</italic></source><year>2015</year><volume>46</volume><fpage>46</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1016/j.mam.2015.08.002</pub-id><pub-id pub-id-type="other">2-s2.0-84948569863</pub-id><pub-id pub-id-type="pmid">26297963</pub-id></element-citation></ref><ref id="B45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chao</surname><given-names>C.-Y.</given-names></name><name><surname>Huang</surname><given-names>C.-J.</given-names></name></person-group><article-title>Bitter gourd (Momordica charantia) extract activates peroxisome proliferator-activated receptors and upregulates the expression of the acyl CoA oxidase gene in H4IIEC3 hepatoma cells</article-title><source><italic toggle="yes">Journal of Biomedical Science</italic></source><year>2003</year><volume>10</volume><issue>6</issue><fpage>782</fpage><lpage>791</lpage><pub-id pub-id-type="doi">10.1007/bf02256331</pub-id><pub-id pub-id-type="pmid">14631118</pub-id></element-citation></ref><ref id="B46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chao</surname><given-names>C.-Y.</given-names></name><name><surname>Yin</surname><given-names>M.-C.</given-names></name><name><surname>Huang</surname><given-names>C.-J.</given-names></name></person-group><article-title>Wild bitter gourd extract up-regulates mRNA expression of PPAR<italic>&#x003b1;</italic>, PPAR<italic>&#x003b3;</italic> and their target genes in C57BL/6J mice</article-title><source><italic toggle="yes">Journal of Ethnopharmacology</italic></source><year>2011</year><volume>135</volume><issue>1</issue><fpage>156</fpage><lpage>161</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2011.03.001</pub-id><pub-id pub-id-type="other">2-s2.0-79955464109</pub-id><pub-id pub-id-type="pmid">21392566</pub-id></element-citation></ref><ref id="B47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shih</surname><given-names>C.-C.</given-names></name><name><surname>Lin</surname><given-names>C.-H.</given-names></name><name><surname>Lin</surname><given-names>W.-L.</given-names></name></person-group><article-title>Effects of Momordica charantia on insulin resistance and visceral obesity in mice on high-fat diet</article-title><source><italic toggle="yes">Diabetes Research and Clinical Practice</italic></source><year>2008</year><volume>81</volume><issue>2</issue><fpage>134</fpage><lpage>143</lpage><pub-id pub-id-type="doi">10.1016/j.diabres.2008.04.023</pub-id><pub-id pub-id-type="other">2-s2.0-47849123027</pub-id><pub-id pub-id-type="pmid">18550200</pub-id></element-citation></ref><ref id="B48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poovitha</surname><given-names>S.</given-names></name><name><surname>Parani</surname><given-names>M.</given-names></name></person-group><article-title>In vitro and in vivo <italic>&#x003b1;</italic>-amylase and <italic>&#x003b1;</italic>-glucosidase inhibiting activities of the protein extracts from two varieties of bitter gourd (Momordica charantia L.)</article-title><source><italic toggle="yes">BMC Complementary and Alternative Medicine</italic></source><year>2016</year><volume>16</volume><issue>Suppl 1</issue><fpage>p. 185</fpage><pub-id pub-id-type="doi">10.1186/s12906-016-1085-1</pub-id><pub-id pub-id-type="other">2-s2.0-84978520130</pub-id></element-citation></ref><ref id="B49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lydia</surname><given-names>D. E.</given-names></name><name><surname>Gupta</surname><given-names>C.</given-names></name><name><surname>Khusro</surname><given-names>A.</given-names></name><name><surname>Salem</surname><given-names>A.</given-names></name></person-group><article-title>Susceptibility of poultry associated bacterial pathogens to Momordica charantia fruits and evaluation of in vitro biological properties</article-title><source><italic toggle="yes">Microbial Pathogenesis</italic></source><year>2019</year><volume>132</volume><fpage>222</fpage><lpage>229</lpage><pub-id pub-id-type="doi">10.1016/j.micpath.2019.05.002</pub-id><pub-id pub-id-type="other">2-s2.0-85065472787</pub-id><pub-id pub-id-type="pmid">31059755</pub-id></element-citation></ref><ref id="B50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chanda</surname><given-names>J.</given-names></name><name><surname>Mukherjee</surname><given-names>P. K.</given-names></name><name><surname>Biswas</surname><given-names>R.</given-names></name><name><surname>Malakar</surname><given-names>D.</given-names></name><name><surname>Pillai</surname><given-names>M.</given-names></name></person-group><article-title>Study of pancreatic lipase inhibition kinetics and LC-QTOF-MS-based identification of bioactive constituents of Momordica charantia fruits</article-title><source><italic toggle="yes">Biomedical Chromatography</italic></source><year>2019</year><volume>33</volume><issue>4</issue><pub-id pub-id-type="publisher-id">e4463</pub-id><pub-id pub-id-type="doi">10.1002/bmc.4463</pub-id><pub-id pub-id-type="other">2-s2.0-85059666057</pub-id></element-citation></ref><ref id="B51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kulkarni</surname><given-names>P.</given-names></name><name><surname>Lohidasan</surname><given-names>S.</given-names></name><name><surname>Mahadik</surname><given-names>K.</given-names></name></person-group><article-title>Isolation, characterisation and investigation of in vitro antidiabetic and antioxidant activity of phytoconstituents from fruit of Momordica charantia Linn</article-title><source><italic toggle="yes">Natural Product Research</italic></source><year>2019</year><fpage>1</fpage><lpage>3</lpage><pub-id pub-id-type="doi">10.1080/14786419.2019.1613400</pub-id><pub-id pub-id-type="other">2-s2.0-85068529654</pub-id></element-citation></ref><ref id="B52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>H.-F.</given-names></name><name><surname>Gan</surname><given-names>C.-Y.</given-names></name></person-group><article-title>Polysaccharide with antioxidant, <italic>&#x003b1;</italic>-amylase inhibitory and ACE inhibitory activities from Momordica charantia</article-title><source><italic toggle="yes">International Journal of Biological Macromolecules</italic></source><year>2016</year><volume>85</volume><fpage>487</fpage><lpage>496</lpage><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2016.01.023</pub-id><pub-id pub-id-type="other">2-s2.0-84954304581</pub-id><pub-id pub-id-type="pmid">26778156</pub-id></element-citation></ref><ref id="B53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nhiem</surname><given-names>N. X.</given-names></name><name><surname>Kiem</surname><given-names>P. V.</given-names></name><name><surname>Minh</surname><given-names>C. V.</given-names></name><etal/></person-group><article-title>
<italic>&#x003b1;</italic>-Glucosidase inhibition properties of cucurbitane-type triterpene glycosides from the fruits of Momordica charantia</article-title><source><italic toggle="yes">Chem Pharm Bull (Tokyo)</italic></source><year>2010</year><volume>58</volume><issue>5</issue><fpage>720</fpage><lpage>724</lpage><pub-id pub-id-type="doi">10.1248/cpb.58.720</pub-id><pub-id pub-id-type="other">2-s2.0-77951735331</pub-id><pub-id pub-id-type="pmid">20460803</pub-id></element-citation></ref><ref id="B54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shivanagoudra</surname><given-names>S. R.</given-names></name><name><surname>Perera</surname><given-names>W. H.</given-names></name><name><surname>Perez</surname><given-names>J. L.</given-names></name><etal/></person-group><article-title>Cucurbitane-type compounds from Momordica charantia: isolation, in vitro antidiabetic, anti-inflammatory activities and in silico modeling approaches</article-title><source><italic toggle="yes">Bioorganic Chemistry</italic></source><year>2019</year><volume>87</volume><fpage>31</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1016/j.bioorg.2019.02.040</pub-id><pub-id pub-id-type="other">2-s2.0-85062463793</pub-id><pub-id pub-id-type="pmid">30856374</pub-id></element-citation></ref><ref id="B55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shivanagoudra</surname><given-names>S. R.</given-names></name><name><surname>Perera</surname><given-names>W. H.</given-names></name><name><surname>Perez</surname><given-names>J. L.</given-names></name><etal/></person-group><article-title>In vitro and in silico elucidation of antidiabetic and anti-inflammatory activities of bioactive compounds from Momordica charantia L</article-title><source><italic toggle="yes">Bioorganic &#x00026; Medicinal Chemistry</italic></source><year>2019</year><volume>27</volume><issue>14</issue><fpage>3097</fpage><lpage>3109</lpage><pub-id pub-id-type="doi">10.1016/j.bmc.2019.05.035</pub-id><pub-id pub-id-type="other">2-s2.0-85066937802</pub-id><pub-id pub-id-type="pmid">31196754</pub-id></element-citation></ref><ref id="B56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>G&#x000fc;dr</surname><given-names>A.</given-names></name></person-group><article-title>Influence of total anthocyanins from bitter melon (momordica charantia linn.) as antidiabetic and radical scavenging agents</article-title><source><italic toggle="yes">Iranian Journal of Pharmaceutical Research</italic></source><year>2016</year><volume>15</volume><issue>1</issue><fpage>301</fpage><lpage>309</lpage><pub-id pub-id-type="pmid">27610171</pub-id></element-citation></ref><ref id="B57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmad</surname><given-names>Z.</given-names></name><name><surname>Zamhuri</surname><given-names>K. F.</given-names></name><name><surname>Yaacob</surname><given-names>A.</given-names></name><etal/></person-group><article-title>In vitro anti-diabetic activities and chemical analysis of polypeptide-k and oil isolated from seeds of Momordica charantia (bitter gourd)</article-title><source><italic toggle="yes">Molecules</italic></source><year>2012</year><volume>17</volume><issue>8</issue><fpage>9631</fpage><lpage>9640</lpage><pub-id pub-id-type="doi">10.3390/molecules17089631</pub-id><pub-id pub-id-type="other">2-s2.0-84865463562</pub-id><pub-id pub-id-type="pmid">22885359</pub-id></element-citation></ref><ref id="B58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mazlan</surname><given-names>F. A.</given-names></name><name><surname>Annuar</surname><given-names>M. S.</given-names></name><name><surname>Sharifuddin</surname><given-names>Y.</given-names></name></person-group><article-title>Biotransformation of Momordica charantia fresh juice by Lactobacillus plantarum BET003 and its putative anti-diabetic potential</article-title><source><italic toggle="yes">Peer J</italic></source><year>2015</year><volume>3</volume><pub-id pub-id-type="publisher-id">e1376</pub-id><pub-id pub-id-type="doi">10.7717/peerj.1376</pub-id><pub-id pub-id-type="other">2-s2.0-84946196516</pub-id></element-citation></ref><ref id="B59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shetty</surname><given-names>A. K.</given-names></name><name><surname>Kumar</surname><given-names>G. S.</given-names></name><name><surname>Sambaiah</surname><given-names>K.</given-names></name><name><surname>Salimath</surname><given-names>P. V.</given-names></name></person-group><article-title>Effect of bitter gourd (Momordica charantia) on glycaemic status in streptozotocin induced diabetic rats</article-title><source><italic toggle="yes">Plant Foods for Human Nutrition</italic></source><year>2005</year><volume>60</volume><issue>3</issue><fpage>109</fpage><lpage>112</lpage><pub-id pub-id-type="doi">10.1007/s11130-005-6837-x</pub-id><pub-id pub-id-type="other">2-s2.0-26244435115</pub-id><pub-id pub-id-type="pmid">16187012</pub-id></element-citation></ref><ref id="B60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rohajatien</surname><given-names>U.</given-names></name><name><surname>Jono</surname><given-names>H.</given-names></name><name><surname>Estiasih</surname><given-names>T.</given-names></name><name><surname>Wahyuni</surname><given-names>E. S.</given-names></name></person-group><article-title>Bitter melon (momordica charantia L.) fruit decreased blood glucose level and improved lipid profile of streptozotocin induced hyperglycemia rats</article-title><source><italic toggle="yes">Current Research in Nutrition and Food Science</italic></source><year>2018</year><volume>6</volume><issue>2</issue><fpage>359</fpage><lpage>370</lpage><pub-id pub-id-type="doi">10.12944/crnfsj.6.2.11</pub-id><pub-id pub-id-type="other">2-s2.0-85052897041</pub-id></element-citation></ref><ref id="B61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malekshahi</surname><given-names>H.</given-names></name><name><surname>Bahrami</surname><given-names>G.</given-names></name><name><surname>Miraghaee</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Momordica charantia reverses type II diabetes in rat</article-title><source><italic toggle="yes">Journal of Food Biochemistry</italic></source><year>2019</year><volume>43</volume><issue>9603</issue><pub-id pub-id-type="publisher-id">e13021</pub-id><pub-id pub-id-type="doi">10.1111/jfbc.13021</pub-id><pub-id pub-id-type="other">2-s2.0-85070978911</pub-id></element-citation></ref><ref id="B62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blum</surname><given-names>A.</given-names></name><name><surname>Loerz</surname><given-names>C.</given-names></name><name><surname>Martin</surname><given-names>H. J.</given-names></name><name><surname>Staab-Weijnitz</surname><given-names>C. A.</given-names></name><name><surname>Maser</surname><given-names>E.</given-names></name></person-group><article-title>Momordica charantia extract, a herbal remedy for type 2 diabetes, contains a specific 11<italic>&#x003b2;</italic>-hydroxysteroid dehydrogenase type 1 inhibitor</article-title><source><italic toggle="yes">Journal of Steroid Biochemistry and Molecular Biology</italic></source><year>2012</year><volume>128</volume><issue>1-2</issue><fpage>51</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1016/j.jsbmb.2011.09.003</pub-id><pub-id pub-id-type="other">2-s2.0-82755188170</pub-id></element-citation></ref><ref id="B63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shih</surname><given-names>C. C.</given-names></name><name><surname>Shlau</surname><given-names>M. T.</given-names></name><name><surname>Lin</surname><given-names>C. H.</given-names></name><name><surname>Wu</surname><given-names>J. B.</given-names></name></person-group><article-title>Momordica charantia ameliorates insulin resistance and dyslipidemia with altered hepatic glucose production and fatty acid synthesis and AMPK phosphorylation in high-fat-fed mice</article-title><source><italic toggle="yes">Phytotherapy Research</italic></source><year>2014</year><volume>28</volume><issue>3</issue><fpage>363</fpage><lpage>371</lpage><pub-id pub-id-type="doi">10.1002/ptr.5003</pub-id><pub-id pub-id-type="other">2-s2.0-84895781801</pub-id><pub-id pub-id-type="pmid">23610006</pub-id></element-citation></ref><ref id="B64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keller</surname><given-names>A. C.</given-names></name><name><surname>Ma</surname><given-names>J.</given-names></name><name><surname>Kavalier</surname><given-names>A.</given-names></name><name><surname>He</surname><given-names>K.</given-names></name><name><surname>Brillantes</surname><given-names>A. M. B.</given-names></name><name><surname>Kennelly</surname><given-names>E. J.</given-names></name></person-group><article-title>Saponins from the traditional medicinal plant Momordica charantia stimulate insulin secretion in vitro</article-title><source><italic toggle="yes">Phytomedicine</italic></source><year>2011</year><volume>19</volume><issue>1</issue><fpage>32</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2011.06.019</pub-id><pub-id pub-id-type="other">2-s2.0-82755189591</pub-id><pub-id pub-id-type="pmid">22133295</pub-id></element-citation></ref><ref id="B65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>T. N.</given-names></name><name><surname>Lu</surname><given-names>K. N.</given-names></name><name><surname>Pai</surname><given-names>Y. P.</given-names></name><name><surname>Chin</surname><given-names>H.</given-names></name><name><surname>Huang</surname><given-names>C. J.</given-names></name></person-group><article-title>Role of GLP-1 in the hypoglycemic effects of wild bitter gourd</article-title><source><italic toggle="yes">Evidence-based Complementary and Alternative Medicine</italic></source><year>2013</year><volume>2013</volume><fpage>13</fpage><pub-id pub-id-type="publisher-id">625892</pub-id><pub-id pub-id-type="doi">10.1155/2013/625892</pub-id><pub-id pub-id-type="other">2-s2.0-84876542396</pub-id></element-citation></ref><ref id="B66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swali</surname><given-names>A.</given-names></name><name><surname>Walker</surname><given-names>E. A.</given-names></name><name><surname>Lavery</surname><given-names>G. G.</given-names></name><name><surname>Tomlinson</surname><given-names>J. W.</given-names></name><name><surname>Stewart</surname><given-names>P. M.</given-names></name></person-group><article-title>11<italic>&#x003b2;</italic>-Hydroxysteroid dehydrogenase type 1 regulates insulin and glucagon secretion in pancreatic islets</article-title><source><italic toggle="yes">DIABETOLOGIA</italic></source><year>2008</year><volume>51</volume><issue>11</issue><fpage>2003</fpage><lpage>2011</lpage><pub-id pub-id-type="doi">10.1007/s00125-008-1137-2</pub-id><pub-id pub-id-type="other">2-s2.0-53549105499</pub-id><pub-id pub-id-type="pmid">18779947</pub-id></element-citation></ref><ref id="B67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davani</surname><given-names>B.</given-names></name><name><surname>Khan</surname><given-names>A.</given-names></name><name><surname>Hult</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Type 1 11<italic>&#x003b2;</italic>-hydroxysteroid dehydrogenase mediates glococorticoid activation and insulin release in pancreatic islets</article-title><source><italic toggle="yes">Journal of Biological Chemistry</italic></source><year>2000</year><volume>275</volume><issue>45</issue><fpage>34841</fpage><lpage>34844</lpage><pub-id pub-id-type="doi">10.1074/jbc.c000600200</pub-id><pub-id pub-id-type="other">2-s2.0-0034634085</pub-id></element-citation></ref><ref id="B68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orts&#x000e4;ter</surname><given-names>H.</given-names></name><name><surname>Alberts</surname><given-names>P.</given-names></name><name><surname>Warpman</surname><given-names>U.</given-names></name><name><surname>Engblom</surname><given-names>L. O. M.</given-names></name><name><surname>Abrahms&#x000e9;n</surname><given-names>L.</given-names></name><name><surname>Bergsten</surname><given-names>P.</given-names></name></person-group><article-title>Regulation of 11<italic>&#x003b2;</italic>-hydroxysteroid dehydrogenase type 1 and glucose-stimulated insulin secretion in pancreatic islets of langerhans</article-title><source><italic toggle="yes">Diabetes/Metabolism Research and Reviews</italic></source><year>2005</year><volume>21</volume><issue>4</issue><fpage>359</fpage><lpage>366</lpage><pub-id pub-id-type="doi">10.1002/dmrr.525</pub-id><pub-id pub-id-type="other">2-s2.0-21744451489</pub-id><pub-id pub-id-type="pmid">15586384</pub-id></element-citation></ref><ref id="B69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>C.</given-names></name><name><surname>Chen</surname><given-names>H.</given-names></name><name><surname>Bai</surname><given-names>W.</given-names></name></person-group><article-title>Characterization of Momordica charantia L. polysaccharide and its protective effect on pancreatic cells injury in STZ-induced diabetic mice</article-title><source><italic toggle="yes">International Journal of Biological Macromolecules</italic></source><year>2018</year><volume>115</volume><fpage>45</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2018.04.039</pub-id><pub-id pub-id-type="other">2-s2.0-85045380950</pub-id><pub-id pub-id-type="pmid">29649536</pub-id></element-citation></ref><ref id="B70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>C.</given-names></name><name><surname>Huang</surname><given-names>M.</given-names></name><name><surname>Hong</surname><given-names>R.</given-names></name><name><surname>Chen</surname><given-names>H.</given-names></name></person-group><article-title>Preparation of a Momordica charantia L. polysaccharide-chromium (III) complex and its anti-hyperglycemic activity in mice with streptozotocin-induced diabetes</article-title><source><italic toggle="yes">International Journal of Biological Macromolecules</italic></source><year>2019</year><volume>122</volume><fpage>619</fpage><lpage>627</lpage><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2018.10.200</pub-id><pub-id pub-id-type="other">2-s2.0-85056192153</pub-id><pub-id pub-id-type="pmid">30391593</pub-id></element-citation></ref><ref id="B71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ru</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>K.</given-names></name><name><surname>Kong</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Shi</surname><given-names>X.</given-names></name><name><surname>Chen</surname><given-names>H.</given-names></name></person-group><article-title>Synthesis of selenylated polysaccharides from Momordica charantia L. and its hypoglycemic activity in streptozotocin-induced diabetic mice</article-title><source><italic toggle="yes">International Journal of Biological Macromolecules</italic></source><year>2020</year><volume>152</volume><fpage>295</fpage><lpage>304</lpage><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2020.02.288</pub-id><pub-id pub-id-type="pmid">32112833</pub-id></element-citation></ref><ref id="B72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmed</surname><given-names>I.</given-names></name><name><surname>Adeghate</surname><given-names>E.</given-names></name><name><surname>Sharma</surname><given-names>A. K.</given-names></name><name><surname>Pallot</surname><given-names>D. J.</given-names></name><name><surname>Singh</surname><given-names>J.</given-names></name></person-group><article-title>Effects of Momordica charantia fruit juice on islet morphology in the pancreas of the streptozotocin-diabetic rat</article-title><source><italic toggle="yes">Diabetes Research and Clinical Practice</italic></source><year>1998</year><volume>40</volume><issue>3</issue><fpage>145</fpage><lpage>151</lpage><pub-id pub-id-type="doi">10.1016/s0168-8227(98)00022-9</pub-id><pub-id pub-id-type="other">2-s2.0-0032104490</pub-id><pub-id pub-id-type="pmid">9716917</pub-id></element-citation></ref><ref id="B73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hafizur</surname><given-names>R. M.</given-names></name><name><surname>Kabir</surname><given-names>N.</given-names></name><name><surname>Chishti</surname><given-names>S.</given-names></name></person-group><article-title>Modulation of pancreatic <italic>&#x003b2;</italic>-cells in neonatally streptozotocin-induced type 2 diabetic rats by the ethanolic extract of Momordica charantia fruit pulp</article-title><source><italic toggle="yes">Natural Product Research</italic></source><year>2011</year><volume>25</volume><issue>4</issue><fpage>353</fpage><lpage>367</lpage><pub-id pub-id-type="doi">10.1080/14786411003766904</pub-id><pub-id pub-id-type="other">2-s2.0-79951740993</pub-id><pub-id pub-id-type="pmid">21328131</pub-id></element-citation></ref><ref id="B74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>N.</given-names></name><name><surname>Gupta</surname><given-names>M.</given-names></name></person-group><article-title>Regeneration of beta cells in islets of Langerhans of pancreas of alloxan diabetic rats by acetone extract of Momordica charantia (Linn.) (bitter gourd) fruits</article-title><source><italic toggle="yes">Indian Journal of Experimental Biology</italic></source><year>2007</year><volume>45</volume><issue>12</issue><fpage>1055</fpage><lpage>1062</lpage><pub-id pub-id-type="pmid">18254212</pub-id></element-citation></ref><ref id="B75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>N.</given-names></name><name><surname>Gupta</surname><given-names>M.</given-names></name><name><surname>Sirohi</surname><given-names>P.</given-names></name><name><surname>Varsha</surname></name></person-group><article-title>Effects of alcoholic extract of Momordica charantia (Linn.) whole fruit powder on the pancreatic islets of alloxan diabetic albino rats</article-title><source><italic toggle="yes">Journal of Environmental Biology</italic></source><year>2008</year><volume>29</volume><issue>1</issue><fpage>101</fpage><lpage>106</lpage><pub-id pub-id-type="pmid">18831340</pub-id></element-citation></ref><ref id="B76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>Q.</given-names></name><name><surname>Zhou</surname><given-names>Z.</given-names></name><name><surname>Ikeda</surname><given-names>Y.</given-names></name></person-group><article-title>PDX1, Neurogenin-3, and MAFA: critical transcription regulators for beta cell development and regeneration</article-title><source><italic toggle="yes">Stem Cell Research and Therapy</italic></source><year>2017</year><volume>8</volume><issue>1</issue><pub-id pub-id-type="doi">10.1186/s13287-017-0694-z</pub-id><pub-id pub-id-type="other">2-s2.0-85032735783</pub-id></element-citation></ref><ref id="B77"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhat</surname><given-names>G. A.</given-names></name><name><surname>Khan</surname><given-names>H. A.</given-names></name><name><surname>Alhomida</surname><given-names>A. S.</given-names></name><name><surname>Sharma</surname><given-names>P.</given-names></name><name><surname>Singh</surname><given-names>R.</given-names></name><name><surname>Paray</surname><given-names>B. A.</given-names></name></person-group><article-title>GLP-I secretion in healthy and diabetic Wistar rats in response to aqueous extract of Momordica charantia</article-title><source><italic toggle="yes">BMC Complementary and Alternative Medicine</italic></source><year>2018</year><volume>18</volume><issue>1</issue><pub-id pub-id-type="doi">10.1186/s12906-018-2242-5</pub-id><pub-id pub-id-type="other">2-s2.0-85048112527</pub-id></element-citation></ref><ref id="B78"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aljohi</surname><given-names>A.</given-names></name><name><surname>Matou-Nasri</surname><given-names>S.</given-names></name><name><surname>Ahmed</surname><given-names>N.</given-names></name></person-group><article-title>Antiglycation and antioxidant properties of Momordica charantia</article-title><source><italic toggle="yes">PLoS One</italic></source><year>2016</year><volume>11</volume><issue>8</issue><pub-id pub-id-type="doi">10.1371/journal.pone.0159985</pub-id><pub-id pub-id-type="other">2-s2.0-84983483119</pub-id></element-citation></ref><ref id="B79"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shan</surname><given-names>B.</given-names></name><name><surname>Xie</surname><given-names>J. H.</given-names></name><name><surname>Zhu</surname><given-names>J. H.</given-names></name><name><surname>Peng</surname><given-names>Y.</given-names></name></person-group><article-title>Ethanol modified supercritical carbon dioxide extraction of flavonoids from Momordica charantia L. and its antioxidant activity</article-title><source><italic toggle="yes">Food and Bioproducts Processing</italic></source><year>2012</year><volume>90</volume><issue>3</issue><fpage>579</fpage><lpage>587</lpage><pub-id pub-id-type="doi">10.1016/j.fbp.2011.09.004</pub-id><pub-id pub-id-type="other">2-s2.0-84860222106</pub-id></element-citation></ref><ref id="B80"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>F.</given-names></name><name><surname>Huang</surname><given-names>G.</given-names></name><name><surname>Yang</surname><given-names>Z.</given-names></name><name><surname>Hou</surname><given-names>Y.</given-names></name></person-group><article-title>Antioxidant activity of Momordica charantia polysaccharide and its derivatives</article-title><source><italic toggle="yes">International Journal of Biological Macromolecules</italic></source><year>2019</year><volume>138</volume><fpage>673</fpage><lpage>680</lpage><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2019.07.129</pub-id><pub-id pub-id-type="other">2-s2.0-85069807249</pub-id><pub-id pub-id-type="pmid">31344411</pub-id></element-citation></ref><ref id="B81"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raish</surname><given-names>M.</given-names></name><name><surname>Ahmad</surname><given-names>A.</given-names></name><name><surname>Jan</surname><given-names>B. L.</given-names></name><etal/></person-group><article-title>Momordica charantia polysaccharides mitigate the progression of STZ induced diabetic nephropathy in rats</article-title><source><italic toggle="yes">International Journal of Biological Macromolecules</italic></source><year>2016</year><volume>91</volume><fpage>394</fpage><lpage>399</lpage><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2016.05.090</pub-id><pub-id pub-id-type="other">2-s2.0-84973512794</pub-id><pub-id pub-id-type="pmid">27238589</pub-id></element-citation></ref><ref id="B82"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wen</surname><given-names>J. J.</given-names></name><name><surname>Gao</surname><given-names>H.</given-names></name><name><surname>Hu</surname><given-names>J. L.</given-names></name><etal/></person-group><article-title>Polysaccharides from fermented Momordica charantia ameliorate obesity in high-fat induced obese rats</article-title><source><italic toggle="yes">Food and Function</italic></source><year>2019</year><volume>10</volume><issue>1</issue><fpage>448</fpage><lpage>457</lpage><pub-id pub-id-type="doi">10.1039/c8fo01609g</pub-id><pub-id pub-id-type="other">2-s2.0-85060199517</pub-id><pub-id pub-id-type="pmid">30628614</pub-id></element-citation></ref><ref id="B83"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beukes</surname><given-names>N.</given-names></name><name><surname>Levendal</surname><given-names>R. A.</given-names></name><name><surname>Frost</surname><given-names>C. L.</given-names></name></person-group><article-title>Selected terpenoids from medicinal plants modulate endoplasmic reticulum stress in metabolic disorders</article-title><source><italic toggle="yes">Journal of Pharmacy and Pharmacology</italic></source><year>2014</year><volume>66</volume><issue>11</issue><fpage>1505</fpage><lpage>1525</lpage><pub-id pub-id-type="doi">10.1111/jphp.12267</pub-id><pub-id pub-id-type="other">2-s2.0-84915819896</pub-id><pub-id pub-id-type="pmid">24821379</pub-id></element-citation></ref><ref id="B84"><label>84</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chong</surname><given-names>W. C.</given-names></name><name><surname>Gundamaraju</surname><given-names>R.</given-names></name><name><surname>Vemuri</surname><given-names>R.</given-names></name><name><surname>Scotti</surname><given-names>M. T.</given-names></name><name><surname>Scotti</surname><given-names>L.</given-names></name></person-group><article-title>Momordicacharantia: a new strategic vision to improve the therapy of endoplasmic reticulum stress</article-title><source><italic toggle="yes">Current Pharmaceutical Design</italic></source><year>2017</year><volume>23</volume><issue>16</issue><fpage>2333</fpage><lpage>2343</lpage><pub-id pub-id-type="doi">10.2174/1381612823666170124141104</pub-id><pub-id pub-id-type="other">2-s2.0-85017201486</pub-id><pub-id pub-id-type="pmid">28120728</pub-id></element-citation></ref><ref id="B85"><label>85</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esser</surname><given-names>N.</given-names></name><name><surname>Legrand-Poels</surname><given-names>S.</given-names></name><name><surname>Piette</surname><given-names>J.</given-names></name><name><surname>Scheen</surname><given-names>A. J.</given-names></name><name><surname>Paquot</surname><given-names>N.</given-names></name></person-group><article-title>Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes</article-title><source><italic toggle="yes">Diabetes Research and Clinical Practice</italic></source><year>2014</year><volume>105</volume><issue>2</issue><fpage>141</fpage><lpage>150</lpage><pub-id pub-id-type="doi">10.1016/j.diabres.2014.04.006</pub-id><pub-id pub-id-type="other">2-s2.0-84906055605</pub-id><pub-id pub-id-type="pmid">24798950</pub-id></element-citation></ref><ref id="B86"><label>86</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kobori</surname><given-names>M.</given-names></name><name><surname>Nakayama</surname><given-names>H.</given-names></name><name><surname>Fukushima</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Bitter gourd suppresses lipopolysaccharide-induced inflammatory responses</article-title><source><italic toggle="yes">Journal of Agricultural and Food Chemistry</italic></source><year>2008</year><volume>56</volume><issue>11</issue><fpage>4004</fpage><lpage>4011</lpage><pub-id pub-id-type="doi">10.1021/jf800052y</pub-id><pub-id pub-id-type="other">2-s2.0-47049106820</pub-id><pub-id pub-id-type="pmid">18489106</pub-id></element-citation></ref><ref id="B87"><label>87</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dwijayanti</surname><given-names>D. R.</given-names></name><name><surname>Shimada</surname><given-names>T.</given-names></name><name><surname>Ishii</surname><given-names>T.</given-names></name><etal/></person-group><article-title>Bitter melon fruit extract has a hypoglycemic effect and reduces hepatic lipid accumulation in ob/ob mice</article-title><source><italic toggle="yes">Phytotherapy Research</italic></source><year>2020</year><volume>34</volume><issue>6</issue><fpage>1338</fpage><lpage>1346</lpage><pub-id pub-id-type="doi">10.1002/ptr.6600</pub-id><pub-id pub-id-type="pmid">31845444</pub-id></element-citation></ref><ref id="B88"><label>88</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nhiem</surname><given-names>N. X.</given-names></name><name><surname>Yen</surname><given-names>P. H.</given-names></name><name><surname>Ngan</surname><given-names>N. T.</given-names></name><etal/></person-group><article-title>Inhibition of nuclear transcription factor-<italic>&#x003ba;</italic>B and activation of peroxisome proliferator-activated receptors in HepG2 cells by cucurbitane-type triterpene glycosides from Momordica charantia</article-title><source><italic toggle="yes">Journal of Medicinal Food</italic></source><year>2012</year><volume>15</volume><issue>4</issue><fpage>369</fpage><lpage>377</lpage><pub-id pub-id-type="doi">10.1089/jmf.2011.1766</pub-id><pub-id pub-id-type="other">2-s2.0-84859076417</pub-id><pub-id pub-id-type="pmid">22248180</pub-id></element-citation></ref><ref id="B89"><label>89</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>C.</given-names></name><name><surname>Ting</surname><given-names>A. T.</given-names></name><name><surname>Seed</surname><given-names>B.</given-names></name></person-group><article-title>PPAR-<italic>&#x003b3;</italic> agonists inhibit production of monocyte inflammatory cytokines</article-title><source><italic toggle="yes">Nature</italic></source><year>1998</year><volume>391</volume><issue>6662</issue><fpage>82</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1038/34184</pub-id><pub-id pub-id-type="other">2-s2.0-0031888958</pub-id><pub-id pub-id-type="pmid">9422509</pub-id></element-citation></ref><ref id="B90"><label>90</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bao</surname><given-names>B.</given-names></name><name><surname>Chen</surname><given-names>Y. G.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Momordica charantia (Bitter Melon) reduces obesity-associated macrophage and mast cell infiltration as well as inflammatory cytokine expression in adipose tissues</article-title><source><italic toggle="yes">PLoS One</italic></source><year>2013</year><volume>8</volume><issue>12</issue><pub-id pub-id-type="publisher-id">e84075</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0084075</pub-id><pub-id pub-id-type="other">2-s2.0-84892934880</pub-id></element-citation></ref><ref id="B91"><label>91</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fachinan</surname><given-names>R.</given-names></name><name><surname>Fagninou</surname><given-names>A.</given-names></name><name><surname>Nekoua</surname><given-names>M. P.</given-names></name><etal/></person-group><article-title>Evidence of immunosuppressive and Th2 immune polarizing effects of antidiabetic momordica charantia fruit juice</article-title><source><italic toggle="yes">Biomed Research International</italic></source><year>2017</year><volume>2017</volume><fpage>13</fpage><pub-id pub-id-type="publisher-id">9478048</pub-id><pub-id pub-id-type="doi">10.1155/2017/9478048</pub-id><pub-id pub-id-type="other">2-s2.0-85027311112</pub-id></element-citation></ref><ref id="B92"><label>92</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fachinan</surname><given-names>R.</given-names></name><name><surname>Yessoufou</surname><given-names>A.</given-names></name><name><surname>Nekoua</surname><given-names>M. P.</given-names></name><name><surname>Moutairou</surname><given-names>K.</given-names></name></person-group><article-title>Effectiveness of antihyperglycemic effect of momordica charantia: implication of T-cell cytokines</article-title><source><italic toggle="yes">Evidence-based Complementary and Alternative Medicine</italic></source><year>2017</year><volume>2017</volume><fpage>8</fpage><pub-id pub-id-type="publisher-id">3707046</pub-id><pub-id pub-id-type="doi">10.1155/2017/3707046</pub-id><pub-id pub-id-type="other">2-s2.0-85042733231</pub-id></element-citation></ref><ref id="B93"><label>93</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adeshirlarijaney</surname><given-names>A.</given-names></name><name><surname>Gewirtz</surname><given-names>A. T.</given-names></name></person-group><article-title>Considering gut microbiota in treatment of type 2 diabetes mellitus</article-title><source><italic toggle="yes">Gut Microbes</italic></source><year>2020</year><volume>11</volume><issue>3</issue><fpage>253</fpage><lpage>264</lpage><pub-id pub-id-type="doi">10.1080/19490976.2020.1717719</pub-id><pub-id pub-id-type="pmid">32005089</pub-id></element-citation></ref><ref id="B94"><label>94</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>Q.</given-names></name><name><surname>Wu</surname><given-names>X.</given-names></name><name><surname>Zhao</surname><given-names>X.</given-names></name><name><surname>Zhao</surname><given-names>L.</given-names></name><name><surname>Tong</surname><given-names>X.</given-names></name></person-group><article-title>New insights into the mechanisms of Chinese herbal products on diabetes: a focus on the &#x0201c;Bacteria-Mucosal immunity-inflammation-diabetes&#x0201d; Axis</article-title><source><italic toggle="yes">Journal of Immunology Research</italic></source><year>2017</year><volume>2017</volume><fpage>13</fpage><pub-id pub-id-type="publisher-id">1813086</pub-id><pub-id pub-id-type="doi">10.1155/2017/1813086</pub-id><pub-id pub-id-type="other">2-s2.0-85042503066</pub-id></element-citation></ref><ref id="B95"><label>95</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ebrahim</surname><given-names>A. M.</given-names></name><name><surname>Alnajjar</surname><given-names>A. O.</given-names></name><name><surname>Mohammed</surname><given-names>M. E.</given-names></name><name><surname>Idris</surname><given-names>A. M.</given-names></name><name><surname>Mohammed</surname><given-names>M.</given-names></name><name><surname>Michalke</surname><given-names>B.</given-names></name></person-group><article-title>Investigation of total zinc contents and zinc-protein profile in medicinal plants traditionally used for diabetes treatment</article-title><source><italic toggle="yes">Biometals</italic></source><year>2020</year><volume>33</volume><issue>1</issue><fpage>65</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1007/s10534-019-00230-3</pub-id><pub-id pub-id-type="pmid">31811450</pub-id></element-citation></ref><ref id="B96"><label>96</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srivastava</surname><given-names>Y.</given-names></name><name><surname>Venkatakrishna-Bhatt</surname><given-names>H.</given-names></name><name><surname>Verma</surname><given-names>Y.</given-names></name><name><surname>Venkaiah</surname><given-names>K.</given-names></name><name><surname>Raval</surname><given-names>B. H.</given-names></name></person-group><article-title>Antidiabetic and adaptogenic properties of Momordica charantia extract: an experimental and clinical evaluation</article-title><source><italic toggle="yes">Phytotherapy Research</italic></source><year>1993</year><volume>7</volume><issue>4</issue><fpage>285</fpage><lpage>289</lpage><pub-id pub-id-type="doi">10.1002/ptr.2650070405</pub-id><pub-id pub-id-type="other">2-s2.0-0027225784</pub-id></element-citation></ref><ref id="B97"><label>97</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akhtar</surname><given-names>M. S.</given-names></name><name><surname>Athar</surname><given-names>M. A.</given-names></name><name><surname>Yaqub</surname><given-names>M.</given-names></name></person-group><article-title>Effect of Momordica charantia on blood glucose level of normal and alloxan-diabetic rabbits</article-title><source><italic toggle="yes">Planta Medica</italic></source><year>1981</year><volume>42</volume><issue>3</issue><fpage>205</fpage><lpage>212</lpage><pub-id pub-id-type="doi">10.1055/s-2007-971629</pub-id><pub-id pub-id-type="pmid">7280086</pub-id></element-citation></ref><ref id="B98"><label>98</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>B.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Design, synthesis and biological evaluation of novel peptide MC2 analogues from Momordica charantia as potential anti-diabetic agents</article-title><source><italic toggle="yes">Organic &#x00026; Biomolecular Chemistry</italic></source><year>2015</year><volume>13</volume><issue>15</issue><fpage>4551</fpage><lpage>4561</lpage><pub-id pub-id-type="doi">10.1039/c5ob00333d</pub-id><pub-id pub-id-type="other">2-s2.0-84926367433</pub-id><pub-id pub-id-type="pmid">25778708</pub-id></element-citation></ref><ref id="B99"><label>99</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>X.</given-names></name><name><surname>Shan</surname><given-names>B.</given-names></name><name><surname>Liao</surname><given-names>C. H.</given-names></name><name><surname>Xie</surname><given-names>J. H.</given-names></name><name><surname>Wen</surname><given-names>P. W.</given-names></name><name><surname>Shi</surname><given-names>J. Y.</given-names></name></person-group><article-title>Anti-diabetic properties of Momordica charantia L. polysaccharide in alloxan-induced diabetic mice</article-title><source><italic toggle="yes">International Journal of Biological Macromolecules</italic></source><year>2015</year><volume>81</volume><fpage>538</fpage><lpage>543</lpage><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2015.08.049</pub-id><pub-id pub-id-type="other">2-s2.0-84940562614</pub-id><pub-id pub-id-type="pmid">26318666</pub-id></element-citation></ref><ref id="B100"><label>100</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmad</surname><given-names>N.</given-names></name><name><surname>Hassan</surname><given-names>M. R.</given-names></name><name><surname>Halder</surname><given-names>H.</given-names></name><name><surname>Bennoor</surname><given-names>K. S.</given-names></name></person-group><article-title>Effect of Momordica charantia (Karolla) extracts on fasting and postprandial serum glucose levels in NIDDM patients</article-title><source><italic toggle="yes">Bangladesh Medical Research Council</italic></source><year>1999</year><volume>25</volume><issue>1</issue><fpage>11</fpage><lpage>13</lpage></element-citation></ref><ref id="B101"><label>101</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>Y.-X.</given-names></name><name><surname>Yang</surname><given-names>Y.-L</given-names></name><name><surname>Huang</surname><given-names>X.-Q.</given-names></name><name><surname>Cao</surname><given-names>W.-W.</given-names></name><name><surname>Wu</surname><given-names>L.</given-names></name></person-group><article-title>Effects of kuhua jiangtang capsule on blood sugar and lipid in patients with type 2 diabetes</article-title><source><italic toggle="yes">Chinese Journal of Clinical Rehabilitation</italic></source><year>2004</year><volume>27</volume><fpage>5994</fpage><lpage>5995</lpage></element-citation></ref><ref id="B102"><label>102</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tongia</surname><given-names>A.</given-names></name><name><surname>Tongia</surname><given-names>S. K.</given-names></name><name><surname>Dave</surname><given-names>M.</given-names></name></person-group><article-title>Phytochemical determination and extraction of Momordica charantia fruit and its hypoglycemic potentiation of oral hypoglycemic drugs in diabetes mellitus (NIDDM)</article-title><source><italic toggle="yes">Indian Journal of Physiology and Pharmacology</italic></source><year>2004</year><volume>48</volume><issue>2</issue><fpage>241</fpage><lpage>244</lpage><pub-id pub-id-type="pmid">15521566</pub-id></element-citation></ref><ref id="B103"><label>103</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rahman</surname><given-names>I. U.</given-names></name><name><surname>Malik</surname><given-names>S. A.</given-names></name><name><surname>Bashir</surname><given-names>M.</given-names></name><name><surname>Khan</surname><given-names>R.</given-names></name><name><surname>Iqbal</surname><given-names>M.</given-names></name></person-group><article-title>Serum sialic acid changes in non-insulin-dependant diabetes mellitus (NIDDM) patients following bitter melon (Momordica charantia) and rosiglitazone (Avandia) treatment</article-title><source><italic toggle="yes">Phytomedicine</italic></source><year>2009</year><volume>16</volume><issue>5</issue><fpage>401</fpage><lpage>405</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2009.01.001</pub-id><pub-id pub-id-type="other">2-s2.0-64649092110</pub-id><pub-id pub-id-type="pmid">19362455</pub-id></element-citation></ref><ref id="B104"><label>104</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fuangchan</surname><given-names>A.</given-names></name><name><surname>Sonthisombat</surname><given-names>P.</given-names></name><name><surname>Seubnukarn</surname><given-names>T.</given-names></name><etal/></person-group><article-title>Hypoglycemic effect of bitter melon compared with metformin in newly diagnosed type 2 diabetes patients</article-title><source><italic toggle="yes">Journal of Ethnopharmacology</italic></source><year>2011</year><volume>134</volume><issue>2</issue><fpage>422</fpage><lpage>428</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2010.12.045</pub-id><pub-id pub-id-type="other">2-s2.0-79952702160</pub-id><pub-id pub-id-type="pmid">21211558</pub-id></element-citation></ref><ref id="B105"><label>105</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inayat</surname><given-names>U. R.</given-names></name><name><surname>Khan</surname><given-names>R. U.</given-names></name><name><surname>Khalil</surname><given-names>U. R.</given-names></name><name><surname>Bashir</surname><given-names>M.</given-names></name></person-group><article-title>Lower hypoglycemic but higher antiatherogenic effects of bitter melon than glibenclamide in type 2 diabetic patients</article-title><source><italic toggle="yes">Nutrition Journal</italic></source><year>2015</year><volume>14</volume><fpage>p. 13</fpage><pub-id pub-id-type="doi">10.1186/1475-2891-14-13</pub-id><pub-id pub-id-type="other">2-s2.0-85017330256</pub-id><pub-id pub-id-type="pmid">25623883</pub-id></element-citation></ref><ref id="B106"><label>106</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cortez-Navarrete</surname><given-names>M.</given-names></name><name><surname>Mart&#x000ed;nez-Abundis</surname><given-names>E.</given-names></name><name><surname>P&#x000e9;rez-Rubio</surname><given-names>K. G.</given-names></name><name><surname>Gonz&#x000e1;lez-Ortiz</surname><given-names>M.</given-names></name><name><surname>M&#x000e9;ndez-Del Villar</surname><given-names>M.</given-names></name></person-group><article-title>Momordica charantia administration improves insulin secretion in type 2 diabetes mellitus</article-title><source><italic toggle="yes">Journal of Medicinal Food</italic></source><year>2018</year><volume>21</volume><issue>7</issue><fpage>672</fpage><lpage>677</lpage><pub-id pub-id-type="doi">10.1089/jmf.2017.0114</pub-id><pub-id pub-id-type="other">2-s2.0-85050255535</pub-id><pub-id pub-id-type="pmid">29431598</pub-id></element-citation></ref><ref id="B107"><label>107</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>C. H.</given-names></name><name><surname>Chen</surname><given-names>E. C. F.</given-names></name><name><surname>Tsay</surname><given-names>H. S.</given-names></name><name><surname>Huang</surname><given-names>C. J.</given-names></name></person-group><article-title>Wild bitter gourd improves metabolic syndrome: a preliminary dietary supplementation trial</article-title><source><italic toggle="yes">Nutrition Journal</italic></source><year>2012</year><volume>11</volume><issue>1</issue><fpage>p. 4</fpage><pub-id pub-id-type="doi">10.1186/1475-2891-11-4</pub-id><pub-id pub-id-type="other">2-s2.0-84855730976</pub-id></element-citation></ref><ref id="B108"><label>108</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boone</surname><given-names>C. H.</given-names></name><name><surname>Stout</surname><given-names>J. R.</given-names></name><name><surname>Gordon</surname><given-names>J. A.</given-names></name><etal/></person-group><article-title>Acute effects of a beverage containing bitter melon extract (CARELA) on postprandial glycemia among prediabetic adults</article-title><source><italic toggle="yes">Nutrition &#x00026; Diabetes</italic></source><year>2017</year><volume>7</volume><issue>1</issue><fpage>p. e241</fpage><pub-id pub-id-type="doi">10.1038/nutd.2016.51</pub-id><pub-id pub-id-type="other">2-s2.0-85037568946</pub-id></element-citation></ref><ref id="B109"><label>109</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krawinkel</surname><given-names>M. B.</given-names></name><name><surname>Ludwig</surname><given-names>C.</given-names></name><name><surname>Swai</surname><given-names>M. E.</given-names></name><name><surname>Yang</surname><given-names>R. Y.</given-names></name><name><surname>Chun</surname><given-names>K. P.</given-names></name><name><surname>Habicht</surname><given-names>S. D.</given-names></name></person-group><article-title>Bitter gourd reduces elevated fasting plasma glucose levels in an intervention study among prediabetics in Tanzania</article-title><source><italic toggle="yes">Journal of Ethnopharmacology</italic></source><year>2018</year><volume>216</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2018.01.016</pub-id><pub-id pub-id-type="other">2-s2.0-85041409599</pub-id><pub-id pub-id-type="pmid">29339109</pub-id></element-citation></ref><ref id="B110"><label>110</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dissanayake</surname><given-names>H. A.</given-names></name><name><surname>Keerthisena</surname><given-names>G. S. P.</given-names></name><name><surname>Gamage</surname><given-names>K. K. K.</given-names></name><etal/></person-group><article-title>Hypoglycaemia in diabetes: do we think enough of the cause? An observational study on prevalence and causes of hypoglycaemia among patients with type 2 diabetes in an out-patient setting in Sri Lanka</article-title><source><italic toggle="yes">BMC Endocrine Disorders</italic></source><year>2018</year><volume>18</volume><issue>1</issue><fpage>p. 35</fpage><pub-id pub-id-type="doi">10.1186/s12902-018-0264-0</pub-id><pub-id pub-id-type="other">2-s2.0-85048282605</pub-id></element-citation></ref><ref id="B111"><label>111</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dans</surname><given-names>A. M. L.</given-names></name><name><surname>Villarruz</surname><given-names>M. V. C.</given-names></name><name><surname>Jimeno</surname><given-names>C. A.</given-names></name><etal/></person-group><article-title>The effect of Momordica charantia capsule preparation on glycemic control in Type 2 Diabetes Mellitus needs further studies</article-title><source><italic toggle="yes">Journal of Clinical Epidemiology</italic></source><year>2007</year><volume>60</volume><issue>6</issue><fpage>554</fpage><lpage>559</lpage><pub-id pub-id-type="doi">10.1016/j.jclinepi.2006.07.009</pub-id><pub-id pub-id-type="other">2-s2.0-34247590159</pub-id><pub-id pub-id-type="pmid">17493509</pub-id></element-citation></ref><ref id="B112"><label>112</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kasbia</surname><given-names>G. S.</given-names></name><name><surname>Arnason</surname><given-names>J. T.</given-names></name><name><surname>Imbeault</surname><given-names>P.</given-names></name></person-group><article-title>No effect of acute, single dose oral administration of Momordica charantia Linn., on glycemia, energy expenditure and appetite: a pilot study in non-diabetic overweight men</article-title><source><italic toggle="yes">Journal of Ethnopharmacology</italic></source><year>2009</year><volume>126</volume><issue>1</issue><fpage>127</fpage><lpage>133</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2009.07.035</pub-id><pub-id pub-id-type="other">2-s2.0-70349786477</pub-id><pub-id pub-id-type="pmid">19665538</pub-id></element-citation></ref><ref id="B113"><label>113</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ooi</surname><given-names>C. P.</given-names></name><name><surname>Yassin</surname><given-names>Z.</given-names></name><name><surname>Hamid</surname><given-names>T. A.</given-names></name></person-group><article-title>Momordica charantia for type 2 diabetes mellitus</article-title><source><italic toggle="yes">Cochrane Database of Systematic Reviews</italic></source><year>2010</year><volume>2</volume><fpage>p. D7845</fpage><pub-id pub-id-type="doi">10.1002/14651858.CD007845.pub2</pub-id></element-citation></ref><ref id="B114"><label>114</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ooi</surname><given-names>C. P.</given-names></name><name><surname>Yassin</surname><given-names>Z.</given-names></name><name><surname>Hamid</surname><given-names>T. A.</given-names></name></person-group><article-title>Momordica charantia for type 2 diabetes mellitus</article-title><source><italic toggle="yes">Cochrane Database of Systematic Reviews</italic></source><year>2012</year><volume>8</volume><fpage>p. D7845</fpage><pub-id pub-id-type="doi">10.1002/14651858.CD007845.pub3</pub-id><pub-id pub-id-type="other">2-s2.0-84866747788</pub-id></element-citation></ref><ref id="B115"><label>115</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teoh</surname><given-names>S. L.</given-names></name><name><surname>Abd</surname><given-names>L. A.</given-names></name><name><surname>Das</surname><given-names>S.</given-names></name></person-group><article-title>Histological changes in the kidneys of experimental diabetic rats fed with Momordica charantia (bitter gourd) extract</article-title><source><italic toggle="yes">Romanian Journal of Morphology and</italic></source><year>2010</year><volume>51</volume><issue>1</issue><fpage>91</fpage><lpage>95</lpage></element-citation></ref><ref id="B116"><label>116</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suresh Kumar</surname><given-names>G.</given-names></name><name><surname>Shetty</surname><given-names>A. K.</given-names></name><name><surname>Salimath</surname><given-names>P. V.</given-names></name></person-group><article-title>Modulatory effect of bitter gourd (Momordica charantia LINN.) on alterations in kidney heparan sulfate in streptozotocin-induced diabetic rats</article-title><source><italic toggle="yes">Journal of Ethnopharmacology</italic></source><year>2008</year><volume>115</volume><issue>2</issue><fpage>276</fpage><lpage>283</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2007.10.002</pub-id><pub-id pub-id-type="other">2-s2.0-37249005197</pub-id><pub-id pub-id-type="pmid">18024034</pub-id></element-citation></ref><ref id="B117"><label>117</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Lei</surname><given-names>S</given-names></name></person-group><article-title>Protective effect and mechanism of momordica charantia extract on retinal ganglion cells of type 2 diabetic rats</article-title><source><italic toggle="yes">Chinese Journal of Coal Industry Medicine</italic></source><year>2020</year><volume>23</volume><issue>1</issue><fpage>11</fpage><lpage>15</lpage></element-citation></ref><ref id="B118"><label>118</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jayasooriya</surname><given-names>A. P.</given-names></name><name><surname>Sakono</surname><given-names>M.</given-names></name><name><surname>Yukizaki</surname><given-names>C.</given-names></name><name><surname>Kawano</surname><given-names>M.</given-names></name><name><surname>Yamamoto</surname><given-names>K.</given-names></name><name><surname>Fukuda</surname><given-names>N.</given-names></name></person-group><article-title>Effects of Momordica charantia powder on serum glucose levels and various lipid parameters in rats fed with cholesterol-free and cholesterol-enriched diets</article-title><source><italic toggle="yes">Journal of Ethnopharmacology</italic></source><year>2000</year><volume>72</volume><issue>1-2</issue><fpage>331</fpage><lpage>336</lpage><pub-id pub-id-type="doi">10.1016/s0378-8741(00)00259-2</pub-id><pub-id pub-id-type="other">2-s2.0-0034284704</pub-id><pub-id pub-id-type="pmid">10967491</pub-id></element-citation></ref><ref id="B119"><label>119</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>Q.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Hypolipidemic and antioxidant potential of bitter gourd (Momordica charantia L.) leaf in mice fed on a high-fat diet</article-title><source><italic toggle="yes">Pakistan Journal of Pharmaceutical Sciences</italic></source><year>2018</year><volume>31</volume><issue>5</issue><fpage>1837</fpage><lpage>1843</lpage><pub-id pub-id-type="pmid">30150178</pub-id></element-citation></ref><ref id="B120"><label>120</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kinoshita</surname><given-names>H.</given-names></name><name><surname>Ogata</surname><given-names>Y.</given-names></name></person-group><article-title>Effect of bitter melon extracts on lipid levels in Japanese subjects: a randomized controlled study</article-title><source><italic toggle="yes">Evidence-Based Complementary and Alternative Medicine</italic></source><year>2018</year><volume>2018</volume><fpage>6</fpage><pub-id pub-id-type="publisher-id">4915784</pub-id><pub-id pub-id-type="doi">10.1155/2018/4915784</pub-id><pub-id pub-id-type="other">2-s2.0-85057025392</pub-id></element-citation></ref><ref id="B121"><label>121</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Czompa</surname><given-names>A.</given-names></name><name><surname>Gyongyosi</surname><given-names>A.</given-names></name><name><surname>Szoke</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Effects of momordica charantia (bitter melon) on ischemic diabetic myocardium</article-title><source><italic toggle="yes">Molecules</italic></source><year>2017</year><volume>22</volume><issue>3</issue><pub-id pub-id-type="doi">10.3390/molecules22030488</pub-id><pub-id pub-id-type="other">2-s2.0-85016285017</pub-id></element-citation></ref><ref id="B122"><label>122</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>P. Y.</given-names></name><name><surname>Shih</surname><given-names>N. L.</given-names></name><name><surname>Hao</surname><given-names>W. R.</given-names></name><name><surname>Chen</surname><given-names>C. C.</given-names></name><name><surname>Liu</surname><given-names>J. C.</given-names></name><name><surname>Sung</surname><given-names>L. C.</given-names></name></person-group><article-title>Inhibitory effects of momordicine I on high-glucose-induced cell proliferation and collagen synthesis in rat cardiac fibroblasts</article-title><source><italic toggle="yes">Oxidative Medicine and Cellular Longevity</italic></source><year>2018</year><volume>2018</volume><fpage>11</fpage><pub-id pub-id-type="publisher-id">3939714</pub-id><pub-id pub-id-type="doi">10.1155/2018/3939714</pub-id><pub-id pub-id-type="other">2-s2.0-85056253666</pub-id></element-citation></ref><ref id="B123"><label>123</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fran&#x000e7;a</surname><given-names>E. L.</given-names></name><name><surname>Ribeiro</surname><given-names>E. B.</given-names></name><name><surname>Scherer</surname><given-names>E. F.</given-names></name><etal/></person-group><article-title>Effects of Momordica charantia L. on the blood rheological properties in diabetic patients</article-title><source><italic toggle="yes">Biomed Research International</italic></source><year>2014</year><volume>2014</volume><fpage>8</fpage><pub-id pub-id-type="publisher-id">840379</pub-id><pub-id pub-id-type="doi">10.1155/2014/840379</pub-id><pub-id pub-id-type="other">2-s2.0-84896262809</pub-id></element-citation></ref><ref id="B124"><label>124</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>R.</given-names></name><name><surname>Garcia-Gomez</surname><given-names>I.</given-names></name><name><surname>Gudehithlu</surname><given-names>K. P.</given-names></name><name><surname>Singh</surname><given-names>A. K.</given-names></name></person-group><article-title>Bitter melon extract promotes granulation tissue growth and angiogenesis in the diabetic wound</article-title><source><italic toggle="yes">Advances in Skin &#x00026; Wound Care</italic></source><year>2017</year><volume>30</volume><issue>1</issue><fpage>16</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1097/01.asw.0000504758.86737.76</pub-id><pub-id pub-id-type="other">2-s2.0-85007273922</pub-id><pub-id pub-id-type="pmid">27984270</pub-id></element-citation></ref><ref id="B125"><label>125</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hussain</surname><given-names>M. S.</given-names></name><name><surname>Jahan</surname><given-names>N.</given-names></name><name><surname>Or</surname><given-names>R. M.</given-names></name><name><surname>Hossain</surname><given-names>M. S.</given-names></name><name><surname>Chen</surname><given-names>U.</given-names></name><name><surname>Rahman</surname><given-names>N.</given-names></name></person-group><article-title>Antihyperlipidemic screening and plasma uric acid reducing potential of Momordica charantia seeds on Swiss albino mice model</article-title><source><italic toggle="yes">Heliyon</italic></source><year>2019</year><volume>5</volume><issue>5</issue><pub-id pub-id-type="publisher-id">e1739</pub-id><pub-id pub-id-type="doi">10.1016/j.heliyon.2019.e01739</pub-id><pub-id pub-id-type="other">2-s2.0-85065792610</pub-id></element-citation></ref><ref id="B126"><label>126</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y. J.</given-names></name><name><surname>Zhu</surname><given-names>J. Q.</given-names></name><name><surname>Fu</surname><given-names>X. Q.</given-names></name><etal/></person-group><article-title>Ribosome-inactivating protein <italic>&#x003b1;</italic>-momorcharin derived from edible plant momordica charantia induces inflammatory responses by activating the NF-kappaB and JNK pathways</article-title><source><italic toggle="yes">Toxins (Basel)</italic></source><year>2019</year><volume>11</volume><issue>12</issue><fpage>p. 694</fpage><pub-id pub-id-type="doi">10.3390/toxins11120694</pub-id></element-citation></ref><ref id="B127"><label>127</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abd</surname><given-names>E. S. E. B.</given-names></name><name><surname>El-Gengaihi</surname><given-names>S. E.</given-names></name><name><surname>El</surname><given-names>S. O.</given-names></name></person-group><article-title>Some toxicological studies of Momordica charantia L. on albino rats in normal and alloxan diabetic rats</article-title><source><italic toggle="yes">Journal of Ethnopharmacology</italic></source><year>2006</year><volume>108</volume><issue>2</issue><fpage>236</fpage><lpage>242</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2006.05.015</pub-id><pub-id pub-id-type="other">2-s2.0-33750348125</pub-id><pub-id pub-id-type="pmid">16815658</pub-id></element-citation></ref><ref id="B128"><label>128</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uche-Nwachi</surname><given-names>E. O.</given-names></name><name><surname>McEwen</surname><given-names>C.</given-names></name></person-group><article-title>Teratogenic effect of the water extract of bitter gourd (Momordica charantia) on the Sprague Dawley rats</article-title><source><italic toggle="yes">African Journal of Traditional, Complementary and Alternative Medicines</italic></source><year>2009</year><volume>7</volume><issue>1</issue><fpage>24</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.4314/ajtcam.v7i1.57228</pub-id></element-citation></ref><ref id="B129"><label>129</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>M. F.</given-names></name><name><surname>Abutaha</surname><given-names>N.</given-names></name><name><surname>Nasr</surname><given-names>F. A.</given-names></name><name><surname>Alqahtani</surname><given-names>A. S.</given-names></name><name><surname>Noman</surname><given-names>O. M.</given-names></name><name><surname>Wadaan</surname><given-names>M.</given-names></name></person-group><article-title>Bitter gourd (Momordica charantia) possess developmental toxicity as revealed by screening the seeds and fruit extracts in zebrafish embryos</article-title><source><italic toggle="yes">BMC Complementary Alternative Medicine</italic></source><year>2019</year><volume>19</volume><issue>1</issue><fpage>p. 184</fpage><pub-id pub-id-type="doi">10.1186/s12906-019-2599-0</pub-id><pub-id pub-id-type="other">2-s2.0-85070507683</pub-id><pub-id pub-id-type="pmid">31340810</pub-id></element-citation></ref><ref id="B130"><label>130</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adewale</surname><given-names>O. O.</given-names></name><name><surname>Oduyemi</surname><given-names>O. I.</given-names></name><name><surname>Ayokunle</surname><given-names>O.</given-names></name></person-group><article-title>Oral administration of leaf extracts of Momordica charantia affect reproductive hormones of adult female Wistar rats</article-title><source><italic toggle="yes">Asian Pacific Journal of Tropical Biomedicine</italic></source><year>2014</year><volume>4</volume><issue>Suppl 1</issue><fpage>S521</fpage><lpage>S524</lpage><pub-id pub-id-type="doi">10.12980/apjtb.4.2014c939</pub-id><pub-id pub-id-type="other">2-s2.0-84922653615</pub-id><pub-id pub-id-type="pmid">25183143</pub-id></element-citation></ref><ref id="B131"><label>131</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patil</surname><given-names>S. A.</given-names></name><name><surname>Patil</surname><given-names>S. B.</given-names></name></person-group><article-title>Toxicological studies of Momordica charantia linn seed extracts in male mice</article-title><source><italic toggle="yes">International Journal of Morphology</italic></source><year>2011</year><volume>29</volume><issue>4</issue><fpage>1212</fpage><lpage>1218</lpage></element-citation></ref></ref-list></back><floats-group><fig id="fig1" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Mechanisms of MC in enhancing glucose uptake and alleviating insulin resistance. MC agents function by inhibiting the expression of SOCS-3 and JNK, activating IRS-1/PI3K/Akt pathway directly or indirectly, and thus promoting the biogenesis and translocation of GLUT4 and suppressing GSK-3. GSK-3 can also be blocked through connecting with MC agents. The activity of AMPK influenced by increased thyroid hormones, adiponectin, and MC agents diametrically also plays a role in stimulating GLUT4 and GS. Besides, MC stimulates adiponectin and the PPAR-<italic>&#x003b1;</italic>/PPAR-<italic>&#x003b3;</italic> pathway that can upregulate ACO and leptin and downregulate resistin to alleviate insulin resistance.</p></caption><graphic xlink:href="ECAM2021-3796265.001"/></fig><fig id="fig2" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Mechanisms of MC in delaying glucose absorption. In the small intestine, MC agents delay the digestion and absorption of food because of the inhibitory activity in <italic>&#x003b1;</italic>-amylase, pancreatic lipase, and <italic>&#x003b1;</italic>-glucosidase. MC agents also activate PI3K, which is associated with less glucose absorption in the jejunum epithelium, and suppress GLUT2, which is associated with decreased reabsorption of glucose in the kidney.</p></caption><graphic xlink:href="ECAM2021-3796265.002"/></fig><fig id="fig3" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Mechanisms of MC in inhibiting gluconeogenesis and glycogenolysis. MC agents can activate AMPK directly and indirectly to reduce glycogenolysis and PEPCK together with G-6-Pase, both of which are key enzymes of gluconeogenesis. At the same time, MC has the ability to suppress 11<italic>&#x003b2;</italic>-HSD1, leading to the reduction of glucocorticoids and further reducing PEPCK to inhibit gluconeogenesis.</p></caption><graphic xlink:href="ECAM2021-3796265.003"/></fig><fig id="fig4" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Mechanisms of MC in protecting islet <italic>&#x003b2;</italic> cells. MC agents promote L-cell allosterism and proliferation through TAS2R or PLC-<italic>&#x003b2;</italic>2 and depolarize L cells to elevate the secretion of GLP-1, which can improve <italic>&#x003b2;</italic>-cell proliferation and insulin secretion. In addition, MC agents inhibit 11<italic>&#x003b2;</italic>-HSD1, decreasing local glucocorticoid aggregation, to ameliorate GSIS and <italic>&#x003b2;</italic> cells. On the other hand, MC agents upregulate insulin and Pdx1 genes, raise serum TAOC, pancreatic GSH, and lower pancreatic MDA to mitigate <italic>&#x003b2;</italic>-cell damage and enhance pancreatic function.</p></caption><graphic xlink:href="ECAM2021-3796265.004"/></fig><fig id="fig5" orientation="portrait" position="float"><label>Figure 5</label><caption><p>Mechanisms of MC in antioxidation. MC agents exhibit extraordinary O<sup>2&#x02212;</sup>, HO&#x000b7;, DPPH, and other free radicals scavenging activity to lighten oxidative stress, resulting in the less production of MDA, AGEs, and CML. MC agents also increase the content of GSH, SOD, and CAT by activating HO-1/Nrf2 pathway. Besides, MC agents have FRAP and capability of ameliorating endoplasmic reticulum stress.</p></caption><graphic xlink:href="ECAM2021-3796265.005"/></fig><fig id="fig6" orientation="portrait" position="float"><label>Figure 6</label><caption><p>Mechanisms of MC in anti-inflammation. MC agents can inhibit TNF-<italic>&#x003b1;</italic> straightly or in the way of stimulating PPAR-<italic>&#x003b3;</italic> and suppressing JNK, to lessen the expression of iNOS and COX-2, thus reducing NO and multiple inflammatory cytokines. MC agents can also inhibit NF-<italic>&#x003ba;</italic>B, which is concerned with TNF-<italic>&#x003b1;</italic>, to lower the production of various inflammatory cytokines. Besides, the expression of IL-1, IL-6, CCL-5, G1p2, and CCL-2 can be inhibited in the macrophages.</p></caption><graphic xlink:href="ECAM2021-3796265.006"/></fig></floats-group></article>